{"transactions":[{"id":3405175,"issuer":{"id":6044,"kind":"organization","name":"DUOS TECHNOLOGIES GROUP, INC.","symbol":"DUOT"},"owners":[{"id":154711,"kind":"organization","name":"21 APRIL FUND, LTD.","position":1,"cik":"0001459708","reported_name":"21 APRIL FUND, LTD.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrants","published_at":"2019-09-27T15:55:02.000Z","date":"2019-09-25","kind":"purchase","acquired":true,"shares":625000,"price":0.001,"value":625.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The Warrants were issued to the Reporting Person in connection with the Reporting Person extending a loan to the Company."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F2","text":"Consists of warrants to acquire 458,125 shares owned by the Reporting Person and warrants to acquire 166,875 shares held by 21 April Fund, LP, an affiliate of the Reporting Person.  The Reporting Person disclaims beneficial ownership of the warrants reported herein except to the extent of the Reporting Person's pecuniary interest therein, and this report shall not be deemed to be an admission that the Reporting Person is the beneficial owner of such warrants for purposes of Section 16 or for any other purpose."}],"balance_after":625000,"derivative":{"exercise_price":0.55,"exercise_date":"2019-09-25","expiration_date":"2024-09-25","underlying":"Common Stock","underlying_shares":625000},"source":{"system":"sec-edgar","filing":"0001459708-19-000001","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1459708/000145970819000001/primary_doc.xml","form_type":"4"}},{"id":3480380,"issuer":{"id":75335,"kind":"organization","name":"DURECT CORP","symbol":"DRRX"},"owners":[{"id":50349,"kind":"organization","name":"First Eagle Investment Management, LLC","position":1,"cik":"0001325447","reported_name":"First Eagle Investment Management, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":156513,"kind":"organization","name":"21 APRIL FUND, L.P.","position":2,"cik":"0001459688","reported_name":"21 APRIL FUND, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":154711,"kind":"organization","name":"21 APRIL FUND, LTD.","position":3,"cik":"0001459708","reported_name":"21 APRIL FUND, LTD.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":156514,"kind":"organization","name":"First Eagle Value in Biotechnology Master Fund, Ltd.","position":4,"cik":"0001457518","reported_name":"First Eagle Value in Biotechnology Master Fund, Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":93499,"kind":"organization","name":"First Eagle Holdings, Inc.","position":5,"cik":"0001637141","reported_name":"First Eagle Holdings, Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2019-06-24T14:12:39.000Z","date":"2019-06-20","kind":"purchase","acquired":true,"shares":4000000,"price":0.52,"value":2080000.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"This Form 4 is filed by 21 April Fund, LP (\"April LP\"), 21 April Ltd. (\"April Ltd.\"), First Eagle Investment Management, LLC (\"FEIM\"), First Eagle Value in Biotechnology Master Fund, Ltd. (\"FEVIBM\") and First Eagle Holdings, Inc. (\"FEHI\" and, collectively with April LP, April Ltd., FEIM and FEVIBM, the \"Entities\"). The Entities disclaim status as a \"group\" for purposes of this Form 4."},{"field":"shares","element":"transactionShares","label":"F2","text":"Pursuant to a prospectus supplement, dated June 20, 2019,  DURECT Corporation (the \"Company\") offered 29,000,000 shares of its common stock, par value $0.0001 per share (the \"Common Stock\") to certain investors of the Company.  Pursuant to the terms that certain Securities Purchase Agreement, dated June 20, 2019, by and among the Company, April LP, April Ltd. and certain other persons, April LP and April Ltd purchased an aggregate of 4,000,000 shares of the Common Stock of the 29,000,000 made available in the offering at a price of $0.52 per share.   The 4,000,000 shares of Common Stock represent 1,300,000 shares of Common Stock directly held by April LP and 2,700,000 shares of Common Stock directly held by April Ltd."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Represents 4,726,893, 16,067,709, 5,586,944 and 95,000 shares of Common Stock held directly by 21 April LP, 21 April Ltd., FEVIBM and certain separately managed accounts, including accounts for which FEIM serves as registered investment adviser (the \"Separately Managed Accounts\"), respectively."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"The shares of Common Stock reported herein are indirectly beneficially owned by FEHI and FEIM, a Delaware limited liability company and an investment adviser registered under the Investment Advisers Act of 1940. FEIM is (i) a general partner of April LP, (ii) the registered investment adviser to FEVIBM as well as to April LP and April Ltd. (collectively, the \"Funds\"), (iii) a subsidiary of FEHI and (iv) the investment adviser to certain of the Separately Managed Accounts. FEHI disclaims beneficial ownership of the shares of Common Stock held directly by the Funds except to the extent, if any, of its pecuniary interest therein, and this report shall not be deemed an admission that FEHI is the beneficial owner of any such securities."}],"balance_after":26476546,"source":{"system":"sec-edgar","filing":"0001567619-19-013856","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1082038/000156761919013856/doc1.xml","form_type":"4"}},{"id":3540683,"issuer":{"id":155143,"kind":"organization","name":"ARADIGM CORP","symbol":"ARDM"},"owners":[{"id":50349,"kind":"organization","name":"First Eagle Investment Management, LLC","position":1,"cik":"0001325447","reported_name":"First Eagle Investment Management, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":154711,"kind":"organization","name":"21 APRIL FUND, LTD.","position":2,"cik":"0001459708","reported_name":"21 APRIL FUND, LTD.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":156514,"kind":"organization","name":"First Eagle Value in Biotechnology Master Fund, Ltd.","position":3,"cik":"0001457518","reported_name":"First Eagle Value in Biotechnology Master Fund, Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":156513,"kind":"organization","name":"21 APRIL FUND, L.P.","position":4,"cik":"0001459688","reported_name":"21 APRIL FUND, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"9.0% Senior Convertible Notes due 2021","published_at":"2019-05-03T16:30:21.000Z","date":"2019-05-01","kind":"other","acquired":true,"shares":85997,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"See Exhibit 99.1."},{"field":"security","element":"securityTitle","label":"F4","text":"See Exhibit 99.1."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"See Exhibit 99.1."},{"field":"kind","element":"transactionCoding","label":"F7","text":"See Exhibit 99.1."},{"field":"shares","element":"transactionShares","label":"F5","text":"See Exhibit 99.1."},{"field":"shares","element":"transactionShares","label":"F7","text":"See Exhibit 99.1."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"See Exhibit 99.1."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F5","text":"See Exhibit 99.1."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F5","text":"See Exhibit 99.1."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"See Exhibit 99.1."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"See Exhibit 99.1."}],"balance_after":3362072,"derivative":{"expiration_date":"2021-04-30","underlying":"Common Stock","underlying_shares":16505},"source":{"system":"sec-edgar","filing":"0001567619-19-009760","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1013238/000156761919009760/doc1.xml","form_type":"4"}},{"id":3774737,"issuer":{"id":155143,"kind":"organization","name":"ARADIGM CORP","symbol":"ARDM"},"owners":[{"id":50349,"kind":"organization","name":"First Eagle Investment Management, LLC","position":1,"cik":"0001325447","reported_name":"First Eagle Investment Management, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":154711,"kind":"organization","name":"21 APRIL FUND, LTD.","position":2,"cik":"0001459708","reported_name":"21 APRIL FUND, LTD.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":156514,"kind":"organization","name":"First Eagle Value in Biotechnology Master Fund, Ltd.","position":3,"cik":"0001457518","reported_name":"First Eagle Value in Biotechnology Master Fund, Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":156513,"kind":"organization","name":"21 APRIL FUND, L.P.","position":4,"cik":"0001459688","reported_name":"21 APRIL FUND, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"9.0% Senior Convertible Notes due 2021","published_at":"2018-11-05T13:52:41.000Z","date":"2018-11-01","kind":"other","acquired":true,"shares":141076,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"See Exhibit 99.1."},{"field":"security","element":"securityTitle","label":"F4","text":"See Exhibit 99.1."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"See Exhibit 99.1."},{"field":"kind","element":"transactionCoding","label":"F7","text":"See Exhibit 99.1."},{"field":"shares","element":"transactionShares","label":"F5","text":"See Exhibit 99.1."},{"field":"shares","element":"transactionShares","label":"F7","text":"See Exhibit 99.1."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"See Exhibit 99.1."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"See Exhibit 99.1."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F5","text":"See Exhibit 99.1."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F5","text":"See Exhibit 99.1."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"See Exhibit 99.1."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"See Exhibit 99.1."}],"balance_after":3276076,"derivative":{"expiration_date":"2021-04-30","underlying":"Common Stock","underlying_shares":27076},"source":{"system":"sec-edgar","filing":"0001567619-18-005067","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1013238/000156761918005067/doc1.xml","form_type":"4"}},{"id":3943142,"issuer":{"id":81388,"kind":"organization","name":"INTEVAC INC","symbol":"IVAC"},"owners":[{"id":50349,"kind":"organization","name":"First Eagle Investment Management, LLC","position":1,"cik":"0001325447","reported_name":"First Eagle Investment Management, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":154711,"kind":"organization","name":"21 APRIL FUND, LTD.","position":2,"cik":"0001459708","reported_name":"21 APRIL FUND, LTD.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":93499,"kind":"organization","name":"First Eagle Holdings, Inc.","position":3,"cik":"0001637141","reported_name":"First Eagle Holdings, Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2018-05-08T16:01:25.000Z","date":"2018-05-04","kind":"purchase","acquired":true,"shares":9000,"price":4.549,"value":40941.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"This Form 4 is filed by 21 April Fund, Ltd. (\"April Ltd.\"), First Eagle Investment Management, LLC (\"FEIM\") and First Eagle Holdings, Inc. (\"FEHI\" and, collectively with April Ltd. and FEIM, the \"Entities\"). The Entities disclaim status as a \"group\" for purposes of this Form 4."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The shares of Common Stock reported herein are indirectly beneficially owned by FEHI and FEIM, a Delaware limited liability company and an investment adviser registered under the Investment Advisers Act of 1940. FEIM is (i) the registered investment adviser to April Ltd., (ii) a subsidiary of FEHI and (iii) investment adviser to certain separately managed accounts which, together with certain separate accounts managed by Michael M. Kellen in his individual capacity holding shares reported by FEIM for which FEIM disclaims beneficial ownership are defined herein as the \"Separately Managed Accounts\". FEHI disclaims Section 16 beneficial ownership of the shares held directly by April Ltd. except to the extent, if any, of its pecuniary interest therein, and this report shall not be deemed an admission that FEHI is the Section 16 beneficial owner of any such securities."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Represents 3,322,615 and 1,626,740 shares held directly by 21 April Ltd. and the Separately Managed Accounts, respectively. FEHI disclaims Section 16 beneficial ownership of the shares held directly by April Ltd. except to the extent, if any, of its pecuniary interest therein, and this report shall not be deemed an admission that FEHI is the Section 16 beneficial owner of any such securities."}],"balance_after":4949355,"source":{"system":"sec-edgar","filing":"0001140361-18-022203","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1001902/000114036118022203/doc1.xml","form_type":"4"}},{"id":3948333,"issuer":{"id":81388,"kind":"organization","name":"INTEVAC INC","symbol":"IVAC"},"owners":[{"id":50349,"kind":"organization","name":"First Eagle Investment Management, LLC","position":1,"cik":"0001325447","reported_name":"First Eagle Investment Management, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":154711,"kind":"organization","name":"21 APRIL FUND, LTD.","position":2,"cik":"0001459708","reported_name":"21 APRIL FUND, LTD.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":93499,"kind":"organization","name":"First Eagle Holdings, Inc.","position":3,"cik":"0001637141","reported_name":"First Eagle Holdings, Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2018-05-03T16:55:36.000Z","date":"2018-05-03","kind":"purchase","acquired":true,"shares":50000,"price":4.6595,"value":232975.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"Represents 3,315,233 and 1,625,122 shares held directly by 21 April Ltd. and the Separately Managed Accounts, respectively. FEHI disclaims Section 16 beneficial ownership of the shares held directly by April Ltd. except to the extent, if any, of its pecuniary interest therein, and this report shall not be deemed an admission that FEHI is the Section 16 beneficial owner of any such securities."}],"balance_after":4940355,"source":{"system":"sec-edgar","filing":"0001140361-18-021543","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1001902/000114036118021543/doc1.xml","form_type":"4"}},{"id":3948332,"issuer":{"id":81388,"kind":"organization","name":"INTEVAC INC","symbol":"IVAC"},"owners":[{"id":50349,"kind":"organization","name":"First Eagle Investment Management, LLC","position":1,"cik":"0001325447","reported_name":"First Eagle Investment Management, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":154711,"kind":"organization","name":"21 APRIL FUND, LTD.","position":2,"cik":"0001459708","reported_name":"21 APRIL FUND, LTD.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":93499,"kind":"organization","name":"First Eagle Holdings, Inc.","position":3,"cik":"0001637141","reported_name":"First Eagle Holdings, Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2018-05-03T16:55:36.000Z","date":"2018-05-02","kind":"purchase","acquired":true,"shares":55700,"price":4.7171,"value":262742.47,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"Represents 3,274,222 and 1,616,133 shares held directly by 21 April Ltd. and the Separately Managed Accounts, respectively. FEHI disclaims Section 16 beneficial ownership of the shares held directly by April Ltd. except to the extent, if any, of its pecuniary interest therein, and this report shall not be deemed an admission that FEHI is the Section 16 beneficial owner of any such securities."}],"balance_after":4890355,"source":{"system":"sec-edgar","filing":"0001140361-18-021543","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1001902/000114036118021543/doc1.xml","form_type":"4"}},{"id":3948331,"issuer":{"id":81388,"kind":"organization","name":"INTEVAC INC","symbol":"IVAC"},"owners":[{"id":50349,"kind":"organization","name":"First Eagle Investment Management, LLC","position":1,"cik":"0001325447","reported_name":"First Eagle Investment Management, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":154711,"kind":"organization","name":"21 APRIL FUND, LTD.","position":2,"cik":"0001459708","reported_name":"21 APRIL FUND, LTD.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":93499,"kind":"organization","name":"First Eagle Holdings, Inc.","position":3,"cik":"0001637141","reported_name":"First Eagle Holdings, Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2018-05-03T16:55:36.000Z","date":"2018-05-01","kind":"purchase","acquired":true,"shares":14900,"price":4.825,"value":71892.5,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Represents 3,228,535 and 1,606,120 shares held directly by 21 April Ltd. and the Separately Managed Accounts, respectively. FEHI disclaims Section 16 beneficial ownership of the shares held directly by April Ltd. except to the extent, if any, of its pecuniary interest therein, and this report shall not be deemed an admission that FEHI is the Section 16 beneficial owner of any such securities."}],"balance_after":4834655,"source":{"system":"sec-edgar","filing":"0001140361-18-021543","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1001902/000114036118021543/doc1.xml","form_type":"4"}},{"id":3948330,"issuer":{"id":81388,"kind":"organization","name":"INTEVAC INC","symbol":"IVAC"},"owners":[{"id":50349,"kind":"organization","name":"First Eagle Investment Management, LLC","position":1,"cik":"0001325447","reported_name":"First Eagle Investment Management, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":154711,"kind":"organization","name":"21 APRIL FUND, LTD.","position":2,"cik":"0001459708","reported_name":"21 APRIL FUND, LTD.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":93499,"kind":"organization","name":"First Eagle Holdings, Inc.","position":3,"cik":"0001637141","reported_name":"First Eagle Holdings, Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2018-05-03T16:55:36.000Z","date":"2018-05-01","kind":"purchase","acquired":true,"shares":35700,"price":4.7645,"value":170092.65,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"This Form 4 is filed by 21 April Fund, Ltd. (\"April Ltd.\"), First Eagle Investment Management, LLC (\"FEIM\") and First Eagle Holdings, Inc. (\"FEHI\" and, collectively with April Ltd. and FEIM, the \"Entities\"). The Entities disclaim status as a \"group\" for purposes of this Form 4."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The shares of Common Stock reported herein are indirectly beneficially owned by FEHI and FEIM, a Delaware limited liability company and an investment adviser registered under the Investment Advisers Act of 1940. FEIM is (i) the registered investment adviser to April Ltd., (ii) a subsidiary of FEHI and (iii) investment adviser to certain separately managed accounts which, together with certain separate accounts managed by Michael M. Kellen in his individual capacity holding shares reported by FEIM for which FEIM disclaims beneficial ownership are defined herein as the \"Separately Managed Accounts\". FEHI disclaims Section 16 beneficial ownership of the shares held directly by April Ltd. except to the extent, if any, of its pecuniary interest therein, and this report shall not be deemed an admission that FEHI is the Section 16 beneficial owner of any such securities."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Represents 3,216,314 and 1,603,441 shares held directly by 21 April Ltd. and the Separately Managed Accounts, respectively. FEHI disclaims Section 16 beneficial ownership of the shares held directly by April Ltd. except to the extent, if any, of its pecuniary interest therein, and this report shall not be deemed an admission that FEHI is the Section 16 beneficial owner of any such securities."}],"balance_after":4819755,"source":{"system":"sec-edgar","filing":"0001140361-18-021543","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1001902/000114036118021543/doc1.xml","form_type":"4"}},{"id":3950082,"issuer":{"id":155143,"kind":"organization","name":"ARADIGM CORP","symbol":"ARDM"},"owners":[{"id":50349,"kind":"organization","name":"First Eagle Investment Management, LLC","position":1,"cik":"0001325447","reported_name":"First Eagle Investment Management, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":154711,"kind":"organization","name":"21 APRIL FUND, LTD.","position":2,"cik":"0001459708","reported_name":"21 APRIL FUND, LTD.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":156514,"kind":"organization","name":"First Eagle Value in Biotechnology Master Fund, Ltd.","position":3,"cik":"0001457518","reported_name":"First Eagle Value in Biotechnology Master Fund, Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":156513,"kind":"organization","name":"21 APRIL FUND, L.P.","position":4,"cik":"0001459688","reported_name":"21 APRIL FUND, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"9.0% Senior Convertible Notes due 2021","published_at":"2018-05-02T16:45:30.000Z","date":"2018-05-01","kind":"other","acquired":true,"shares":25913,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"See Exhibit 99.1"},{"field":"security","element":"securityTitle","label":"F4","text":"See Exhibit 99.1"},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"See Exhibit 99.1"},{"field":"kind","element":"transactionCoding","label":"F7","text":"See Exhibit 99.1"},{"field":"shares","element":"transactionShares","label":"F7","text":"See Exhibit 99.1"},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"See Exhibit 99.1"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"See Exhibit 99.1"},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F5","text":"See Exhibit 99.1"},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F5","text":"See Exhibit 99.1"},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"See Exhibit 99.1"},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"See Exhibit 99.1"}],"balance_after":3135000,"derivative":{"expiration_date":"2021-04-30","underlying":"Common Stock","underlying_shares":601728},"source":{"system":"sec-edgar","filing":"0001140361-18-021276","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1013238/000114036118021276/doc1.xml","form_type":"4"}},{"id":3954020,"issuer":{"id":81388,"kind":"organization","name":"INTEVAC INC","symbol":"IVAC"},"owners":[{"id":50349,"kind":"organization","name":"First Eagle Investment Management, LLC","position":1,"cik":"0001325447","reported_name":"First Eagle Investment Management, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":154711,"kind":"organization","name":"21 APRIL FUND, LTD.","position":2,"cik":"0001459708","reported_name":"21 APRIL FUND, LTD.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":93499,"kind":"organization","name":"First Eagle Holdings, Inc.","position":3,"cik":"0001637141","reported_name":"First Eagle Holdings, Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2018-04-30T16:04:09.000Z","date":"2018-04-26","kind":"purchase","acquired":true,"shares":100000,"price":6.175,"value":617500.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"This Form 4 is filed by 21 April Fund, Ltd. (\"April Ltd.\"), First Eagle Investment Management, LLC (\"FEIM\") and First Eagle Holdings, Inc. (\"FEHI\" and, collectively with April Ltd. and FEIM, the \"Entities\"). The Entities disclaim status as a \"group\" for purposes of this Form 4."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The shares of Common Stock reported herein are indirectly beneficially owned by FEHI and FEIM, a Delaware limited liability company and an investment adviser registered under the Investment Advisers Act of 1940. FEIM is (i) the registered investment adviser to April Ltd., (ii) a subsidiary of FEHI and (iii) investment adviser to certain separately managed accounts which, together with certain separate accounts managed by Michael M. Kellen in his individual capacity holding shares reported by FEIM for which FEIM disclaims beneficial ownership are defined herein as the \"Separately Managed Accounts\". FEHI disclaims Section 16 beneficial ownership of the shares held directly by April Ltd. except to the extent, if any, of its pecuniary interest therein, and this report shall not be deemed an admission that FEHI is the Section 16 beneficial owner of any such securities."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Represents 3,187,032 and 1,597,023 shares held directly by 21 April Ltd. and the Separately Managed Accounts, respectively. FEHI disclaims Section 16 beneficial ownership of the shares held directly by April Ltd. except to the extent, if any, of its pecuniary interest therein, and this report shall not be deemed an admission that FEHI is the Section 16 beneficial owner of any such securities."}],"balance_after":4784055,"source":{"system":"sec-edgar","filing":"0001140361-18-020485","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1001902/000114036118020485/doc1.xml","form_type":"4"}},{"id":3956441,"issuer":{"id":81388,"kind":"organization","name":"INTEVAC INC","symbol":"IVAC"},"owners":[{"id":50349,"kind":"organization","name":"First Eagle Investment Management, LLC","position":1,"cik":"0001325447","reported_name":"First Eagle Investment Management, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":154711,"kind":"organization","name":"21 APRIL FUND, LTD.","position":2,"cik":"0001459708","reported_name":"21 APRIL FUND, LTD.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":93499,"kind":"organization","name":"First Eagle Holdings, Inc.","position":3,"cik":"0001637141","reported_name":"First Eagle Holdings, Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2018-04-26T13:16:29.000Z","date":"2018-04-23","kind":"purchase","acquired":true,"shares":121997,"price":5.9995,"value":731921.0015,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The amendment is for purposes of reflecting the correct purchase price."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"Represents 3,105,230 and 1,578,825 shares held directly by 21 April Ltd. and the Separately Managed Accounts, respectively. FEHI disclaims Section 16 beneficial ownership of the shares held directly by April Ltd. except to the extent, if any, of its pecuniary interest therein, and this report shall not be deemed an admission that FEHI is the Section 16 beneficial owner of any such securities."}],"balance_after":4684055,"source":{"system":"sec-edgar","filing":"0001140361-18-019696","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1001902/000114036118019696/doc1.xml","form_type":"4/A","original_submission_date":"2018-04-25"}},{"id":3956440,"issuer":{"id":81388,"kind":"organization","name":"INTEVAC INC","symbol":"IVAC"},"owners":[{"id":50349,"kind":"organization","name":"First Eagle Investment Management, LLC","position":1,"cik":"0001325447","reported_name":"First Eagle Investment Management, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":154711,"kind":"organization","name":"21 APRIL FUND, LTD.","position":2,"cik":"0001459708","reported_name":"21 APRIL FUND, LTD.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":93499,"kind":"organization","name":"First Eagle Holdings, Inc.","position":3,"cik":"0001637141","reported_name":"First Eagle Holdings, Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2018-04-26T13:16:29.000Z","date":"2018-04-23","kind":"purchase","acquired":true,"shares":100003,"price":6,"value":600018.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"This Form 4 is filed by 21 April Fund, Ltd. (\"April Ltd.\"), First Eagle Investment Management, LLC (\"FEIM\") and First Eagle Holdings, Inc. (\"FEHI\" and, collectively with April Ltd. and FEIM, the \"Entities\"). The Entities disclaim status as a \"group\" for purposes of this Form 4."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The shares of Common Stock reported herein are indirectly beneficially owned by FEHI and FEIM, a Delaware limited liability company and an investment adviser registered under the Investment Advisers Act of 1940. FEIM is (i) the registered investment adviser to April Ltd., (ii) a subsidiary of FEHI and (iii) investment adviser to certain separately managed accounts which, together with certain separate accounts managed by Michael M. Kellen in his individual capacity holding shares reported by FEIM for which FEIM disclaims beneficial ownership are defined herein as the \"Separately Managed Accounts\". FEHI disclaims Section 16 beneficial ownership of the shares held directly by April Ltd. except to the extent, if any, of its pecuniary interest therein, and this report shall not be deemed an admission that FEHI is the Section 16 beneficial owner of any such securities."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Represents 3,005,434 and 1,556,624 shares held directly by 21 April Ltd. and the Separately Managed Accounts, respectively. FEHI disclaims Section 16 beneficial ownership of the shares held directly by April Ltd. except to the extent, if any, of its pecuniary interest therein, and this report shall not be deemed an admission that FEHI is the Section 16 beneficial owner of any such securities."}],"balance_after":4562058,"source":{"system":"sec-edgar","filing":"0001140361-18-019696","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1001902/000114036118019696/doc1.xml","form_type":"4/A","original_submission_date":"2018-04-25"}},{"id":3957390,"issuer":{"id":81388,"kind":"organization","name":"INTEVAC INC","symbol":"IVAC"},"owners":[{"id":50349,"kind":"organization","name":"First Eagle Investment Management, LLC","position":1,"cik":"0001325447","reported_name":"First Eagle Investment Management, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":154711,"kind":"organization","name":"21 APRIL FUND, LTD.","position":2,"cik":"0001459708","reported_name":"21 APRIL FUND, LTD.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":93499,"kind":"organization","name":"First Eagle Holdings, Inc.","position":3,"cik":"0001637141","reported_name":"First Eagle Holdings, Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2018-04-25T16:12:26.000Z","date":"2018-04-23","kind":"purchase","acquired":true,"shares":121997,"price":6.25,"value":762481.25,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Represents 3,105,230 and 1,578,825 shares held directly by 21 April Ltd. and the Separately Managed Accounts, respectively. FEHI disclaims Section 16 beneficial ownership of the shares held directly by April Ltd. except to the extent, if any, of its pecuniary interest therein, and this report shall not be deemed an admission that FEHI is the Section 16 beneficial owner of any such securities."}],"balance_after":4684055,"source":{"system":"sec-edgar","filing":"0001140361-18-019529","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1001902/000114036118019529/doc1.xml","form_type":"4"}},{"id":3957389,"issuer":{"id":81388,"kind":"organization","name":"INTEVAC INC","symbol":"IVAC"},"owners":[{"id":50349,"kind":"organization","name":"First Eagle Investment Management, LLC","position":1,"cik":"0001325447","reported_name":"First Eagle Investment Management, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":154711,"kind":"organization","name":"21 APRIL FUND, LTD.","position":2,"cik":"0001459708","reported_name":"21 APRIL FUND, LTD.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":93499,"kind":"organization","name":"First Eagle Holdings, Inc.","position":3,"cik":"0001637141","reported_name":"First Eagle Holdings, Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2018-04-25T16:12:26.000Z","date":"2018-04-23","kind":"purchase","acquired":true,"shares":100003,"price":6,"value":600018.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"This Form 4 is filed by 21 April Fund, Ltd. (\"April Ltd.\"), First Eagle Investment Management, LLC (\"FEIM\") and First Eagle Holdings, Inc. (\"FEHI\" and, collectively with April Ltd. and FEIM, the \"Entities\"). The Entities disclaim status as a \"group\" for purposes of this Form 4."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The shares of Common Stock reported herein are indirectly beneficially owned by FEHI and FEIM, a Delaware limited liability company and an investment adviser registered under the Investment Advisers Act of 1940. FEIM is (i) the registered investment adviser to April Ltd., (ii) a subsidiary of FEHI and (iii) investment adviser to certain separately managed accounts which, together with certain separate accounts managed by Michael M. Kellen in his individual capacity holding shares reported by FEIM for which FEIM disclaims beneficial ownership are defined herein as the \"Separately Managed Accounts\". FEHI disclaims Section 16 beneficial ownership of the shares held directly by April Ltd. except to the extent, if any, of its pecuniary interest therein, and this report shall not be deemed an admission that FEHI is the Section 16 beneficial owner of any such securities."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Represents 3,005,434 and 1,556,624 shares held directly by 21 April Ltd. and the Separately Managed Accounts, respectively. FEHI disclaims Section 16 beneficial ownership of the shares held directly by April Ltd. except to the extent, if any, of its pecuniary interest therein, and this report shall not be deemed an admission that FEHI is the Section 16 beneficial owner of any such securities."}],"balance_after":4562058,"source":{"system":"sec-edgar","filing":"0001140361-18-019529","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1001902/000114036118019529/doc1.xml","form_type":"4"}},{"id":3982371,"issuer":{"id":81388,"kind":"organization","name":"INTEVAC INC","symbol":"IVAC"},"owners":[{"id":50349,"kind":"organization","name":"First Eagle Investment Management, LLC","position":1,"cik":"0001325447","reported_name":"First Eagle Investment Management, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":154711,"kind":"organization","name":"21 APRIL FUND, LTD.","position":2,"cik":"0001459708","reported_name":"21 APRIL FUND, LTD.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":93499,"kind":"organization","name":"First Eagle Holdings, Inc.","position":3,"cik":"0001637141","reported_name":"First Eagle Holdings, Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2018-03-27T16:33:35.000Z","date":"2018-03-23","kind":"purchase","acquired":true,"shares":28449,"price":6.0498,"value":172110.7602,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"This Form 4 is filed by 21 April Ltd. (\"April Ltd.\"), First Eagle Investment Management, LLC (\"FEIM\") and First Eagle Holdings, Inc. (\"FEHI\" and, collectively with April Ltd. and FEIM, the \"Entities\"). The Entities disclaim status as a \"group\" for purposes of this Form 4."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The shares of Common Stock reported herein are indirectly beneficially owned by FEHI and FEIM, a Delaware limited liability company and an investment adviser registered under the Investment Advisers Act of 1940. FEIM is (i) the registered investment adviser to April Ltd., (ii) a subsidiary of FEHI and (iii) investment adviser to certain separately managed accounts which, together with certain separate accounts managed by Michael M. Kellen in his individual capacity holding shares reported by FEIM for which FEIM disclaims beneficial ownership are defined herein as the \"Separately Managed Accounts\". FEHI disclaims Section 16 beneficial ownership of the shares held directly by April Ltd. except to the extent, if any, of its pecuniary interest therein, and this report shall not be deemed an admission that FEHI is the Section 16 beneficial owner of any such securities."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Represents 2,923,630 and 1,538,425 shares held directly by 21 April Ltd. and the Separately Managed Accounts, respectively. FEHI disclaims Section 16 beneficial ownership of the shares held directly by April Ltd. except to the extent, if any, of its pecuniary interest therein, and this report shall not be deemed an admission that FEHI is the Section 16 beneficial owner of any such securities."}],"balance_after":4462055,"source":{"system":"sec-edgar","filing":"0001140361-18-015242","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1001902/000114036118015242/doc1.xml","form_type":"4"}},{"id":4034919,"issuer":{"id":81388,"kind":"organization","name":"INTEVAC INC","symbol":"IVAC"},"owners":[{"id":50349,"kind":"organization","name":"First Eagle Investment Management, LLC","position":1,"cik":"0001325447","reported_name":"First Eagle Investment Management, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":154711,"kind":"organization","name":"21 APRIL FUND, LTD.","position":2,"cik":"0001459708","reported_name":"21 APRIL FUND, LTD.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":93499,"kind":"organization","name":"First Eagle Holdings, Inc.","position":3,"cik":"0001637141","reported_name":"First Eagle Holdings, Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2018-02-26T14:20:24.000Z","date":"2018-02-22","kind":"purchase","acquired":true,"shares":4009,"price":6.1,"value":24454.9,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"This Form 4 is filed by 21 April Ltd. (\"April Ltd.\"), First Eagle Investment Management, LLC (\"FEIM\") and First Eagle Holdings, Inc. (\"FEHI\" and, collectively with April Ltd. and FEIM, the \"Entities\"). The Entities disclaim status as a \"group\" for purposes of this Form 4."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The shares of Common Stock reported herein are indirectly beneficially owned by FEHI and FEIM, a Delaware limited liability company and an investment adviser registered under the Investment Advisers Act of 1940. FEIM is (i) the registered investment adviser to April Ltd., (ii) a subsidiary of FEHI and (iii) investment adviser to certain separately managed accounts which, together with certain separate accounts managed by Michael M. Kellen in his individual capacity holding shares reported by FEIM for which FEIM disclaims beneficial ownership are defined herein as the \"Separately Managed Accounts\". FEHI disclaims Section 16 beneficial ownership of the shares held directly by April Ltd. except to the extent, if any, of its pecuniary interest therein, and this report shall not be deemed an admission that FEHI is the Section 16 beneficial owner of any such securities."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Represents 2,897,030 and 1,536,576 shares held directly by 21 April Ltd. and the Separately Managed Accounts, respectively. FEHI disclaims Section 16 beneficial ownership of the shares held directly by April Ltd. except to the extent, if any, of its pecuniary interest therein, and this report shall not be deemed an admission that FEHI is the Section 16 beneficial owner of any such securities."}],"balance_after":4433606,"source":{"system":"sec-edgar","filing":"0001140361-18-010092","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1001902/000114036118010092/doc1.xml","form_type":"4"}},{"id":4045380,"issuer":{"id":81388,"kind":"organization","name":"INTEVAC INC","symbol":"IVAC"},"owners":[{"id":50349,"kind":"organization","name":"First Eagle Investment Management, LLC","position":1,"cik":"0001325447","reported_name":"First Eagle Investment Management, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":154711,"kind":"organization","name":"21 APRIL FUND, LTD.","position":2,"cik":"0001459708","reported_name":"21 APRIL FUND, LTD.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":93499,"kind":"organization","name":"First Eagle Holdings, Inc.","position":3,"cik":"0001637141","reported_name":"First Eagle Holdings, Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2018-02-21T12:20:21.000Z","date":"2018-02-20","kind":"purchase","acquired":true,"shares":3120,"price":6.15,"value":19188.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Represents 2,893,494 and 1,536,103 shares held directly by 21 April Ltd. and the Separately Managed Accounts, respectively. FEHI disclaims Section 16 beneficial ownership of the shares held directly by April Ltd. except to the extent, if any, of its pecuniary interest therein, and this report shall not be deemed an admission that FEHI is the Section 16 beneficial owner of any such securities."}],"balance_after":4429597,"source":{"system":"sec-edgar","filing":"0001140361-18-009244","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1001902/000114036118009244/doc1.xml","form_type":"4"}},{"id":4045379,"issuer":{"id":81388,"kind":"organization","name":"INTEVAC INC","symbol":"IVAC"},"owners":[{"id":50349,"kind":"organization","name":"First Eagle Investment Management, LLC","position":1,"cik":"0001325447","reported_name":"First Eagle Investment Management, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":154711,"kind":"organization","name":"21 APRIL FUND, LTD.","position":2,"cik":"0001459708","reported_name":"21 APRIL FUND, LTD.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":93499,"kind":"organization","name":"First Eagle Holdings, Inc.","position":3,"cik":"0001637141","reported_name":"First Eagle Holdings, Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2018-02-21T12:20:21.000Z","date":"2018-02-16","kind":"purchase","acquired":true,"shares":30000,"price":6.2417,"value":187251.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"This Form 4 is filed by 21 April Ltd. (\"April Ltd.\"), First Eagle Investment Management, LLC (\"FEIM\") and First Eagle Holdings, Inc. (\"FEHI\" and, collectively with April Ltd. and FEIM, the \"Entities\"). The Entities disclaim status as a \"group\" for purposes of this Form 4."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The shares of Common Stock reported herein are indirectly beneficially owned by FEHI and FEIM, a Delaware limited liability company and an investment adviser registered under the Investment Advisers Act of 1940. FEIM is (i) the registered investment adviser to April Ltd., (ii) a subsidiary of FEHI and (iii) investment adviser to certain separately managed accounts which, together with certain separate accounts managed by Michael M. Kellen in his individual capacity holding shares reported by FEIM for which FEIM disclaims beneficial ownership are defined herein as the \"Separately Managed Accounts\". FEHI disclaims Section 16 beneficial ownership of the shares held directly by April Ltd. except to the extent, if any, of its pecuniary interest therein, and this report shall not be deemed an admission that FEHI is the Section 16 beneficial owner of any such securities."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Represents 2,890,742 and 1,535,735 shares held directly by 21 April Ltd. and the Separately Managed Accounts, respectively. FEHI disclaims Section 16 beneficial ownership of the shares held directly by April Ltd. except to the extent, if any, of its pecuniary interest therein, and this report shall not be deemed an admission that FEHI is the Section 16 beneficial owner of any such securities."}],"balance_after":4426477,"source":{"system":"sec-edgar","filing":"0001140361-18-009244","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1001902/000114036118009244/doc1.xml","form_type":"4"}},{"id":4055882,"issuer":{"id":81388,"kind":"organization","name":"INTEVAC INC","symbol":"IVAC"},"owners":[{"id":50349,"kind":"organization","name":"First Eagle Investment Management, LLC","position":1,"cik":"0001325447","reported_name":"First Eagle Investment Management, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":154711,"kind":"organization","name":"21 APRIL FUND, LTD.","position":2,"cik":"0001459708","reported_name":"21 APRIL FUND, LTD.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":156514,"kind":"organization","name":"First Eagle Value in Biotechnology Master Fund, Ltd.","position":3,"cik":"0001457518","reported_name":"First Eagle Value in Biotechnology Master Fund, Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":93499,"kind":"organization","name":"First Eagle Holdings, Inc.","position":4,"cik":"0001637141","reported_name":"First Eagle Holdings, Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2018-02-15T16:48:36.000Z","date":"2018-02-15","kind":"purchase","acquired":true,"shares":14791,"price":6.25,"value":92443.75,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"Represents 2,864,282, 299,662 and 1,232,533 shares held directly by 21 April Ltd., FEVIBM and the Separately Managed Accounts, respectively. FEHI disclaims Section 16 beneficial ownership of the shares held directly by the Funds except to the extent, if any, of its pecuniary interest therein, and this report shall not be deemed an admission that FEHI is the Section 16 beneficial owner of any such securities."}],"balance_after":4396477,"source":{"system":"sec-edgar","filing":"0001140361-18-008694","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1001902/000114036118008694/doc1.xml","form_type":"4"}},{"id":4055881,"issuer":{"id":81388,"kind":"organization","name":"INTEVAC INC","symbol":"IVAC"},"owners":[{"id":50349,"kind":"organization","name":"First Eagle Investment Management, LLC","position":1,"cik":"0001325447","reported_name":"First Eagle Investment Management, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":154711,"kind":"organization","name":"21 APRIL FUND, LTD.","position":2,"cik":"0001459708","reported_name":"21 APRIL FUND, LTD.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":156514,"kind":"organization","name":"First Eagle Value in Biotechnology Master Fund, Ltd.","position":3,"cik":"0001457518","reported_name":"First Eagle Value in Biotechnology Master Fund, Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":93499,"kind":"organization","name":"First Eagle Holdings, Inc.","position":4,"cik":"0001637141","reported_name":"First Eagle Holdings, Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2018-02-15T16:48:36.000Z","date":"2018-02-14","kind":"purchase","acquired":true,"shares":6500,"price":6.25,"value":40625.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Represents 2,851,236, 299,662 and 1,230,788 shares held directly by 21 April Ltd., FEVIBM and the Separately Managed Accounts, respectively. FEHI disclaims Section 16 beneficial ownership of the shares held directly by the Funds except to the extent, if any, of its pecuniary interest therein, and this report shall not be deemed an admission that FEHI is the Section 16 beneficial owner of any such securities."}],"balance_after":4381686,"source":{"system":"sec-edgar","filing":"0001140361-18-008694","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1001902/000114036118008694/doc1.xml","form_type":"4"}},{"id":4055880,"issuer":{"id":81388,"kind":"organization","name":"INTEVAC INC","symbol":"IVAC"},"owners":[{"id":50349,"kind":"organization","name":"First Eagle Investment Management, LLC","position":1,"cik":"0001325447","reported_name":"First Eagle Investment Management, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":154711,"kind":"organization","name":"21 APRIL FUND, LTD.","position":2,"cik":"0001459708","reported_name":"21 APRIL FUND, LTD.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":156514,"kind":"organization","name":"First Eagle Value in Biotechnology Master Fund, Ltd.","position":3,"cik":"0001457518","reported_name":"First Eagle Value in Biotechnology Master Fund, Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":93499,"kind":"organization","name":"First Eagle Holdings, Inc.","position":4,"cik":"0001637141","reported_name":"First Eagle Holdings, Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2018-02-15T16:48:36.000Z","date":"2018-02-13","kind":"purchase","acquired":true,"shares":2100,"price":6.25,"value":13125.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"This Form 4 is filed by 21 April Ltd. (\"April Ltd.\"), First Eagle Investment Management, LLC (\"FEIM\"), First Eagle Value in Biotechnology Master Fund, Ltd. (\"FEVIBM\") and First Eagle Holdings, Inc. (\"FEHI\" and, collectively with April Ltd., FEIM and FEVIBM, the \"Entities\"). The Entities disclaim status as a \"group\" for purposes of this Form 4."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The shares of Common Stock reported herein are indirectly beneficially owned by FEHI and FEIM, a Delaware limited liability company and an investment adviser registered under the Investment Advisers Act of 1940. FEIM is (i) the registered investment adviser to FEVIBM as well as to April Ltd. (collectively, the \"Funds\"), (ii) a subsidiary of FEHI and (iii) investment adviser to certain separately managed accounts which, together with certain separate accounts managed by Michael M. Kellen in his individual capacity holding shares reported by FEIM for which FEIM disclaims beneficial ownership are defined herein as the \"Separately Managed Accounts\". FEHI disclaims Section 16 beneficial ownership of the shares held directly by the Funds except to the extent, if any, of its pecuniary interest therein, and this report shall not be deemed an admission that FEHI is the Section 16 beneficial owner of any such securities."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Represents 2,845,503, 299,662 and 1,230,021 shares held directly by 21 April Ltd., FEVIBM and the Separately Managed Accounts, respectively. FEHI disclaims Section 16 beneficial ownership of the shares held directly by the Funds except to the extent, if any, of its pecuniary interest therein, and this report shall not be deemed an admission that FEHI is the Section 16 beneficial owner of any such securities."}],"balance_after":4375186,"source":{"system":"sec-edgar","filing":"0001140361-18-008694","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1001902/000114036118008694/doc1.xml","form_type":"4"}},{"id":4063858,"issuer":{"id":81388,"kind":"organization","name":"INTEVAC INC","symbol":"IVAC"},"owners":[{"id":50349,"kind":"organization","name":"First Eagle Investment Management, LLC","position":1,"cik":"0001325447","reported_name":"First Eagle Investment Management, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":154711,"kind":"organization","name":"21 APRIL FUND, LTD.","position":2,"cik":"0001459708","reported_name":"21 APRIL FUND, LTD.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":156514,"kind":"organization","name":"First Eagle Value in Biotechnology Master Fund, Ltd.","position":3,"cik":"0001457518","reported_name":"First Eagle Value in Biotechnology Master Fund, Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":93499,"kind":"organization","name":"First Eagle Holdings, Inc.","position":4,"cik":"0001637141","reported_name":"First Eagle Holdings, Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2018-02-13T14:37:23.000Z","date":"2018-02-12","kind":"purchase","acquired":true,"shares":12672,"price":6.2175,"value":78788.16,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Represents 2,843,651, 299,662 and 1,229,773 shares held directly by 21 April Ltd., FEVIBM and the Separately Managed Accounts, respectively. FEHI disclaims Section 16 beneficial ownership of the shares held directly by the Funds except to the extent, if any, of its pecuniary interest therein, and this report shall not be deemed an admission that FEHI is the Section 16 beneficial owner of any such securities."}],"balance_after":4373086,"source":{"system":"sec-edgar","filing":"0001140361-18-006973","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1001902/000114036118006973/doc1.xml","form_type":"4"}},{"id":4063857,"issuer":{"id":81388,"kind":"organization","name":"INTEVAC INC","symbol":"IVAC"},"owners":[{"id":50349,"kind":"organization","name":"First Eagle Investment Management, LLC","position":1,"cik":"0001325447","reported_name":"First Eagle Investment Management, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":154711,"kind":"organization","name":"21 APRIL FUND, LTD.","position":2,"cik":"0001459708","reported_name":"21 APRIL FUND, LTD.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":156514,"kind":"organization","name":"First Eagle Value in Biotechnology Master Fund, Ltd.","position":3,"cik":"0001457518","reported_name":"First Eagle Value in Biotechnology Master Fund, Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":93499,"kind":"organization","name":"First Eagle Holdings, Inc.","position":4,"cik":"0001637141","reported_name":"First Eagle Holdings, Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2018-02-13T14:37:23.000Z","date":"2018-02-09","kind":"purchase","acquired":true,"shares":22600,"price":6.2051,"value":140235.26,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"This Form 4 is filed by 21 April Ltd. (\"April Ltd.\"), First Eagle Investment Management, LLC (\"FEIM\"), First Eagle Value in Biotechnology Master Fund, Ltd. (\"FEVIBM\") and First Eagle Holdings, Inc. (\"FEHI\" and, collectively with April Ltd., FEIM and FEVIBM, the \"Entities\"). The Entities disclaim status as a \"group\" for purposes of this Form 4."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The shares of Common Stock reported herein are indirectly beneficially owned by FEHI and FEIM, a Delaware limited liability company and an investment adviser registered under the Investment Advisers Act of 1940. FEIM is (i) the registered investment adviser to FEVIBM as well as to April Ltd. (collectively, the \"Funds\"), (ii) a subsidiary of FEHI and (iii) investment adviser to certain separately managed accounts which, together with certain separate accounts managed by Michael M. Kellen in his individual capacity holding shares reported by FEIM for which FEIM disclaims beneficial ownership are defined herein as the \"Separately Managed Accounts\". FEHI disclaims Section 16 beneficial ownership of the shares held directly by the Funds except to the extent, if any, of its pecuniary interest therein, and this report shall not be deemed an admission that FEHI is the Section 16 beneficial owner of any such securities."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Represents 2,832,474, 299,662 and 1,228,278 shares held directly by 21 April Ltd., FEVIBM and the Separately Managed Accounts, respectively. FEHI disclaims Section 16 beneficial ownership of the shares held directly by the Funds except to the extent, if any, of its pecuniary interest therein, and this report shall not be deemed an admission that FEHI is the Section 16 beneficial owner of any such securities."}],"balance_after":4360414,"source":{"system":"sec-edgar","filing":"0001140361-18-006973","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1001902/000114036118006973/doc1.xml","form_type":"4"}},{"id":4069085,"issuer":{"id":81388,"kind":"organization","name":"INTEVAC INC","symbol":"IVAC"},"owners":[{"id":50349,"kind":"organization","name":"First Eagle Investment Management, LLC","position":1,"cik":"0001325447","reported_name":"First Eagle Investment Management, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":154711,"kind":"organization","name":"21 APRIL FUND, LTD.","position":2,"cik":"0001459708","reported_name":"21 APRIL FUND, LTD.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":156514,"kind":"organization","name":"First Eagle Value in Biotechnology Master Fund, Ltd.","position":3,"cik":"0001457518","reported_name":"First Eagle Value in Biotechnology Master Fund, Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":93499,"kind":"organization","name":"First Eagle Holdings, Inc.","position":4,"cik":"0001637141","reported_name":"First Eagle Holdings, Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2018-02-09T15:24:59.000Z","date":"2018-02-08","kind":"purchase","acquired":true,"shares":17500,"price":6.3192,"value":110586.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Represents 2,812,541, 299,662 and 1,225,611 shares held directly by 21 April Ltd., FEVIBM and the Separately Managed Accounts, respectively. FEHI disclaims Section 16 beneficial ownership of the shares held directly by the Funds except to the extent, if any, of its pecuniary interest therein, and this report shall not be deemed an admission that FEHI is the Section 16 beneficial owner of any such securities."}],"balance_after":4337814,"source":{"system":"sec-edgar","filing":"0001140361-18-006264","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1001902/000114036118006264/doc1.xml","form_type":"4"}},{"id":4069084,"issuer":{"id":81388,"kind":"organization","name":"INTEVAC INC","symbol":"IVAC"},"owners":[{"id":50349,"kind":"organization","name":"First Eagle Investment Management, LLC","position":1,"cik":"0001325447","reported_name":"First Eagle Investment Management, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":154711,"kind":"organization","name":"21 APRIL FUND, LTD.","position":2,"cik":"0001459708","reported_name":"21 APRIL FUND, LTD.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":156514,"kind":"organization","name":"First Eagle Value in Biotechnology Master Fund, Ltd.","position":3,"cik":"0001457518","reported_name":"First Eagle Value in Biotechnology Master Fund, Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":93499,"kind":"organization","name":"First Eagle Holdings, Inc.","position":4,"cik":"0001637141","reported_name":"First Eagle Holdings, Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2018-02-09T15:24:59.000Z","date":"2018-02-07","kind":"purchase","acquired":true,"shares":3800,"price":6.348,"value":24122.4,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"This Form 4 is filed by 21 April Ltd. (\"April Ltd.\"), First Eagle Investment Management, LLC (\"FEIM\"), First Eagle Value in Biotechnology Master Fund, Ltd. (\"FEVIBM\") and First Eagle Holdings, Inc. (\"FEHI\" and, collectively with April Ltd., FEIM and FEVIBM, the \"Entities\"). The Entities disclaim status as a \"group\" for purposes of this Form 4."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The shares of Common Stock reported herein are indirectly beneficially owned by FEHI and FEIM, a Delaware limited liability company and an investment adviser registered under the Investment Advisers Act of 1940. FEIM is (i) the registered investment adviser to FEVIBM as well as to April Ltd. (collectively, the \"Funds\"), (ii) a subsidiary of FEHI and (iii) investment adviser to certain separately managed accounts which, together with certain separate accounts managed by Michael M. Kellen in his individual capacity holding shares reported by FEIM for which FEIM disclaims beneficial ownership are defined herein as the \"Separately Managed Accounts\". FEHI disclaims Section 16 beneficial ownership of the shares held directly by the Funds except to the extent, if any, of its pecuniary interest therein, and this report shall not be deemed an admission that FEHI is the Section 16 beneficial owner of any such securities."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Represents 2,797,106, 299,662 and 1,223,546 shares held directly by 21 April Ltd., FEVIBM and the Separately Managed Accounts, respectively. FEHI disclaims Section 16 beneficial ownership of the shares held directly by the Funds except to the extent, if any, of its pecuniary interest therein, and this report shall not be deemed an admission that FEHI is the Section 16 beneficial owner of any such securities."}],"balance_after":4320314,"source":{"system":"sec-edgar","filing":"0001140361-18-006264","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1001902/000114036118006264/doc1.xml","form_type":"4"}},{"id":4072607,"issuer":{"id":81388,"kind":"organization","name":"INTEVAC INC","symbol":"IVAC"},"owners":[{"id":50349,"kind":"organization","name":"First Eagle Investment Management, LLC","position":1,"cik":"0001325447","reported_name":"First Eagle Investment Management, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":154711,"kind":"organization","name":"21 APRIL FUND, LTD.","position":2,"cik":"0001459708","reported_name":"21 APRIL FUND, LTD.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":156514,"kind":"organization","name":"First Eagle Value in Biotechnology Master Fund, Ltd.","position":3,"cik":"0001457518","reported_name":"First Eagle Value in Biotechnology Master Fund, Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":93499,"kind":"organization","name":"First Eagle Holdings, Inc.","position":4,"cik":"0001637141","reported_name":"First Eagle Holdings, Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2018-02-07T12:51:52.000Z","date":"2018-02-06","kind":"purchase","acquired":true,"shares":45834,"price":6.328,"value":290037.552,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"Represents 2,793,754, 299,662 and 1,223,098 shares held directly by 21 April Ltd., FEVIBM and the Separately Managed Accounts, respectively. FEHI disclaims Section 16 beneficial ownership of the shares held directly by the Funds except to the extent, if any, of its pecuniary interest therein, and this report shall not be deemed an admission that FEHI is the Section 16 beneficial owner of any such securities."}],"balance_after":4316514,"source":{"system":"sec-edgar","filing":"0001140361-18-005487","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1001902/000114036118005487/doc1.xml","form_type":"4"}},{"id":4072606,"issuer":{"id":81388,"kind":"organization","name":"INTEVAC INC","symbol":"IVAC"},"owners":[{"id":50349,"kind":"organization","name":"First Eagle Investment Management, LLC","position":1,"cik":"0001325447","reported_name":"First Eagle Investment Management, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":154711,"kind":"organization","name":"21 APRIL FUND, LTD.","position":2,"cik":"0001459708","reported_name":"21 APRIL FUND, LTD.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":156514,"kind":"organization","name":"First Eagle Value in Biotechnology Master Fund, Ltd.","position":3,"cik":"0001457518","reported_name":"First Eagle Value in Biotechnology Master Fund, Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":93499,"kind":"organization","name":"First Eagle Holdings, Inc.","position":4,"cik":"0001637141","reported_name":"First Eagle Holdings, Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2018-02-07T12:51:52.000Z","date":"2018-02-05","kind":"purchase","acquired":true,"shares":5000,"price":6.325,"value":31625.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Represents 2,753,328, 299,662 and 1,217,690 shares held directly by 21 April Ltd., FEVIBM and the Separately Managed Accounts, respectively. FEHI disclaims Section 16 beneficial ownership of the shares held directly by the Funds except to the extent, if any, of its pecuniary interest therein, and this report shall not be deemed an admission that FEHI is the Section 16 beneficial owner of any such securities."}],"balance_after":4270680,"source":{"system":"sec-edgar","filing":"0001140361-18-005487","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1001902/000114036118005487/doc1.xml","form_type":"4"}},{"id":4072605,"issuer":{"id":81388,"kind":"organization","name":"INTEVAC INC","symbol":"IVAC"},"owners":[{"id":50349,"kind":"organization","name":"First Eagle Investment Management, LLC","position":1,"cik":"0001325447","reported_name":"First Eagle Investment Management, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":154711,"kind":"organization","name":"21 APRIL FUND, LTD.","position":2,"cik":"0001459708","reported_name":"21 APRIL FUND, LTD.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":156514,"kind":"organization","name":"First Eagle Value in Biotechnology Master Fund, Ltd.","position":3,"cik":"0001457518","reported_name":"First Eagle Value in Biotechnology Master Fund, Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":93499,"kind":"organization","name":"First Eagle Holdings, Inc.","position":4,"cik":"0001637141","reported_name":"First Eagle Holdings, Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2018-02-07T12:51:52.000Z","date":"2018-02-05","kind":"purchase","acquired":true,"shares":35498,"price":6.3256,"value":224546.1488,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"This Form 4 is filed by 21 April Ltd. (\"April Ltd.\"), First Eagle Investment Management, LLC (\"FEIM\"), First Eagle Value in Biotechnology Master Fund, Ltd. (\"FEVIBM\") and First Eagle Holdings, Inc. (\"FEHI\" and, collectively with April Ltd., FEIM and FEVIBM, the \"Entities\"). The Entities disclaim status as a \"group\" for purposes of this Form 4."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The shares of Common Stock reported herein are indirectly beneficially owned by FEHI and FEIM, a Delaware limited liability company and an investment adviser registered under the Investment Advisers Act of 1940. FEIM is (i) the registered investment adviser to FEVIBM as well as to April Ltd. (collectively, the \"Funds\"), (ii) a subsidiary of FEHI and (iii) investment adviser to certain separately managed accounts which, together with certain separate accounts managed by Michael M. Kellen in his individual capacity holding shares reported by FEIM for which FEIM disclaims beneficial ownership are defined herein as the \"Separately Managed Accounts\". FEHI disclaims Section 16 beneficial ownership of the shares held directly by the Funds except to the extent, if any, of its pecuniary interest therein, and this report shall not be deemed an admission that FEHI is the Section 16 beneficial owner of any such securities."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Represents 2,748,918, 299,662 and 1,217,100 shares held directly by 21 April Ltd., FEVIBM and the Separately Managed Accounts, respectively. FEHI disclaims Section 16 beneficial ownership of the shares held directly by the Funds except to the extent, if any, of its pecuniary interest therein, and this report shall not be deemed an admission that FEHI is the Section 16 beneficial owner of any such securities."}],"balance_after":4265680,"source":{"system":"sec-edgar","filing":"0001140361-18-005487","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1001902/000114036118005487/doc1.xml","form_type":"4"}},{"id":4077273,"issuer":{"id":81388,"kind":"organization","name":"INTEVAC INC","symbol":"IVAC"},"owners":[{"id":50349,"kind":"organization","name":"First Eagle Investment Management, LLC","position":1,"cik":"0001325447","reported_name":"First Eagle Investment Management, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":154711,"kind":"organization","name":"21 APRIL FUND, LTD.","position":2,"cik":"0001459708","reported_name":"21 APRIL FUND, LTD.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":156514,"kind":"organization","name":"First Eagle Value in Biotechnology Master Fund, Ltd.","position":3,"cik":"0001457518","reported_name":"First Eagle Value in Biotechnology Master Fund, Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":93499,"kind":"organization","name":"First Eagle Holdings, Inc.","position":4,"cik":"0001637141","reported_name":"First Eagle Holdings, Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2018-02-05T12:19:59.000Z","date":"2018-02-02","kind":"purchase","acquired":true,"shares":10300,"price":6.4757,"value":66699.71,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"Represents 2,717,609, 299,662 and 1,212,911 shares held directly by 21 April Ltd., FEVIBM and the Separately Managed Accounts, respectively. FEHI disclaims Section 16 beneficial ownership of the shares held directly by the Funds except to the extent, if any, of its pecuniary interest therein, and this report shall not be deemed an admission that FEHI is the Section 16 beneficial owner of any such securities."}],"balance_after":4230182,"source":{"system":"sec-edgar","filing":"0001140361-18-004930","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1001902/000114036118004930/doc1.xml","form_type":"4"}},{"id":4077272,"issuer":{"id":81388,"kind":"organization","name":"INTEVAC INC","symbol":"IVAC"},"owners":[{"id":50349,"kind":"organization","name":"First Eagle Investment Management, LLC","position":1,"cik":"0001325447","reported_name":"First Eagle Investment Management, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":154711,"kind":"organization","name":"21 APRIL FUND, LTD.","position":2,"cik":"0001459708","reported_name":"21 APRIL FUND, LTD.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":156514,"kind":"organization","name":"First Eagle Value in Biotechnology Master Fund, Ltd.","position":3,"cik":"0001457518","reported_name":"First Eagle Value in Biotechnology Master Fund, Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":93499,"kind":"organization","name":"First Eagle Holdings, Inc.","position":4,"cik":"0001637141","reported_name":"First Eagle Holdings, Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2018-02-05T12:19:59.000Z","date":"2018-02-02","kind":"purchase","acquired":true,"shares":35208,"price":6.5885,"value":231967.908,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Represents 2,708,524, 299,662 and 1,211,696 shares held directly by 21 April Ltd., FEVIBM and the Separately Managed Accounts, respectively. FEHI disclaims Section 16 beneficial ownership of the shares held directly by the Funds except to the extent, if any, of its pecuniary interest therein, and this report shall not be deemed an admission that FEHI is the Section 16 beneficial owner of any such securities."}],"balance_after":4219882,"source":{"system":"sec-edgar","filing":"0001140361-18-004930","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1001902/000114036118004930/doc1.xml","form_type":"4"}},{"id":4077271,"issuer":{"id":81388,"kind":"organization","name":"INTEVAC INC","symbol":"IVAC"},"owners":[{"id":50349,"kind":"organization","name":"First Eagle Investment Management, LLC","position":1,"cik":"0001325447","reported_name":"First Eagle Investment Management, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":154711,"kind":"organization","name":"21 APRIL FUND, LTD.","position":2,"cik":"0001459708","reported_name":"21 APRIL FUND, LTD.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":156514,"kind":"organization","name":"First Eagle Value in Biotechnology Master Fund, Ltd.","position":3,"cik":"0001457518","reported_name":"First Eagle Value in Biotechnology Master Fund, Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":93499,"kind":"organization","name":"First Eagle Holdings, Inc.","position":4,"cik":"0001637141","reported_name":"First Eagle Holdings, Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2018-02-05T12:19:59.000Z","date":"2018-02-01","kind":"purchase","acquired":true,"shares":400,"price":6.475,"value":2590.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"This Form 4 is filed by 21 April Ltd. (\"April Ltd.\"), First Eagle Investment Management, LLC (\"FEIM\"), First Eagle Value in Biotechnology Master Fund, Ltd. (\"FEVIBM\") and First Eagle Holdings, Inc. (\"FEHI\" and, collectively with April Ltd., FEIM and FEVIBM, the \"Entities\"). The Entities disclaim status as a \"group\" for purposes of this Form 4."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The shares of Common Stock reported herein are indirectly beneficially owned by FEHI and FEIM, a Delaware limited liability company and an investment adviser registered under the Investment Advisers Act of 1940. FEIM is (i) the registered investment adviser to FEVIBM as well as to April Ltd. (collectively, the \"Funds\"), (ii) a subsidiary of FEHI and (iii) investment adviser to certain separately managed accounts which, together with certain separate accounts managed by Michael M. Kellen in his individual capacity holding shares reported by FEIM for which FEIM disclaims beneficial ownership are defined herein as the \"Separately Managed Accounts\". FEHI disclaims Section 16 beneficial ownership of the shares held directly by the Funds except to the extent, if any, of its pecuniary interest therein, and this report shall not be deemed an admission that FEHI is the Section 16 beneficial owner of any such securities."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Represents 2,677,471, 299,662 and 1,207,541 shares held directly by 21 April Ltd., FEVIBM and the Separately Managed Accounts, respectively. FEHI disclaims Section 16 beneficial ownership of the shares held directly by the Funds except to the extent, if any, of its pecuniary interest therein, and this report shall not be deemed an admission that FEHI is the Section 16 beneficial owner of any such securities."}],"balance_after":4184674,"source":{"system":"sec-edgar","filing":"0001140361-18-004930","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1001902/000114036118004930/doc1.xml","form_type":"4"}},{"id":4079722,"issuer":{"id":7037,"kind":"organization","name":"INVE Technologies, Inc.","symbol":"INVE"},"owners":[{"id":50349,"kind":"organization","name":"First Eagle Investment Management, LLC","position":1,"cik":"0001325447","reported_name":"First Eagle Investment Management, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":154711,"kind":"organization","name":"21 APRIL FUND, LTD.","position":2,"cik":"0001459708","reported_name":"21 APRIL FUND, LTD.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":93499,"kind":"organization","name":"First Eagle Holdings, Inc.","position":3,"cik":"0001637141","reported_name":"First Eagle Holdings, Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2018-02-02T22:29:53.000Z","date":"2018-02-01","kind":"other","acquired":false,"shares":105500,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"This Form 4 is filed by 21 April Fund, Ltd. (\"April Ltd.\"), First Eagle Investment Management, LLC (\"FEIM\") and First Eagle Holdings, Inc. (\"FEHI\" and, collectively with April Ltd. and FEIM, the \"Entities\"). The Entities disclaim status as a \"group\" for purposes of this Form 4."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"As of February 1, 2018, certain separately managed accounts terminated their relationship with, and are no longer advised by, FEIM. The positions held in such accounts are therefore no longer included herein."},{"field":"acquired","element":"transactionAcquiredDisposedCode","label":"F2","text":"As of February 1, 2018, certain separately managed accounts terminated their relationship with, and are no longer advised by, FEIM. The positions held in such accounts are therefore no longer included herein."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The shares of Common Stock reported herein are indirectly beneficially owned by FEHI and FEIM, a Delaware limited liability company and an investment adviser registered under the Investment Advisers Act of 1940. FEIM is (i) the registered investment adviser to April Ltd., and (ii) a subsidiary of FEHI.  FEHI disclaims Section 16 beneficial ownership of the shares except to the extent, if any, of its pecuniary interest therein, and this report shall not be deemed an admission that FEHI is the Section 16 beneficial owner of any such securities."}],"balance_after":1853004,"source":{"system":"sec-edgar","filing":"0001140361-18-004824","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1036044/000114036118004824/doc1.xml","form_type":"4"}},{"id":4079996,"issuer":{"id":155143,"kind":"organization","name":"ARADIGM CORP","symbol":"ARDM"},"owners":[{"id":50349,"kind":"organization","name":"First Eagle Investment Management, LLC","position":1,"cik":"0001325447","reported_name":"First Eagle Investment Management, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":154711,"kind":"organization","name":"21 APRIL FUND, LTD.","position":2,"cik":"0001459708","reported_name":"21 APRIL FUND, LTD.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":156514,"kind":"organization","name":"First Eagle Value in Biotechnology Master Fund, Ltd.","position":3,"cik":"0001457518","reported_name":"First Eagle Value in Biotechnology Master Fund, Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":156513,"kind":"organization","name":"21 APRIL FUND, L.P.","position":4,"cik":"0001459688","reported_name":"21 APRIL FUND, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2018-02-02T17:33:00.000Z","date":"2018-02-01","kind":"other","acquired":false,"shares":479477,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"This Form 4 is filed by 21 April Fund, LP (\"April LP\"), 21 April Ltd. (\"April Ltd.\"), First Eagle Investment Management, LLC (\"FEIM\"), First Eagle Value in Biotechnology Master Fund, Ltd. (\"FEVIBM\") and First Eagle Holdings, Inc. (\"FEHI\" and, collectively with April LP, April Ltd., FEIM and FEVIBM, the \"Entities\"). The Entities disclaim status as a \"group\" for purposes of this Form 4."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"As of February 1, 2018, certain separately managed accounts terminated their relationship with, and are no longer advised by, FEIM. The positions held in such accounts are therefore no longer included herein."},{"field":"acquired","element":"transactionAcquiredDisposedCode","label":"F2","text":"As of February 1, 2018, certain separately managed accounts terminated their relationship with, and are no longer advised by, FEIM. The positions held in such accounts are therefore no longer included herein."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The shares of Common Stock reported herein are indirectly beneficially owned by FEHI and FEIM, a Delaware limited liability company and an investment adviser registered under the Investment Advisers Act of 1940. FEIM is (i) a general partner of April LP, (ii) the registered investment adviser to FEVIBM as well as to April LP and April Ltd. (collectively, the \"Funds\"), (iii) a subsidiary of FEHI and (iv) FEIM is investment adviser to certain of the Separately Managed Accounts. FEHI disclaims Section 16 beneficial ownership of the shares held directly by the Funds except to the extent, if any, of its pecuniary interest therein, and this report shall not be deemed an admission that FEHI is the Section 16 beneficial owner of any such securities."}],"balance_after":4210186,"source":{"system":"sec-edgar","filing":"0001140361-18-004826","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1013238/000114036118004826/doc1.xml","form_type":"4"}},{"id":4082412,"issuer":{"id":81388,"kind":"organization","name":"INTEVAC INC","symbol":"IVAC"},"owners":[{"id":50349,"kind":"organization","name":"First Eagle Investment Management, LLC","position":1,"cik":"0001325447","reported_name":"First Eagle Investment Management, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":154711,"kind":"organization","name":"21 APRIL FUND, LTD.","position":2,"cik":"0001459708","reported_name":"21 APRIL FUND, LTD.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":156514,"kind":"organization","name":"First Eagle Value in Biotechnology Master Fund, Ltd.","position":3,"cik":"0001457518","reported_name":"First Eagle Value in Biotechnology Master Fund, Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":93499,"kind":"organization","name":"First Eagle Holdings, Inc.","position":4,"cik":"0001637141","reported_name":"First Eagle Holdings, Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2018-02-01T14:18:48.000Z","date":"2018-02-01","kind":"other","acquired":false,"shares":293646,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F7","text":"As of February 1, 2018, certain separately managed accounts terminated their relationship with, and are no longer advised by, FEIM.  The positions held in such accounts are therefore no longer included herein."},{"field":"acquired","element":"transactionAcquiredDisposedCode","label":"F7","text":"As of February 1, 2018, certain separately managed accounts terminated their relationship with, and are no longer advised by, FEIM.  The positions held in such accounts are therefore no longer included herein."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F8","text":"Represents 2,677,118, 299,662 and 1,207,494 shares held directly by 21 April Ltd., FEVIBM and the Separately Managed Accounts, respectively. FEHI disclaims Section 16 beneficial ownership of the shares held directly by the Funds except to the extent, if any, of its pecuniary interest therein, and this report shall not be deemed an admission that FEHI is the Section 16 beneficial owner of any such securities."}],"balance_after":4184274,"source":{"system":"sec-edgar","filing":"0001140361-18-004372","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1001902/000114036118004372/doc1.xml","form_type":"4"}},{"id":4082411,"issuer":{"id":81388,"kind":"organization","name":"INTEVAC INC","symbol":"IVAC"},"owners":[{"id":50349,"kind":"organization","name":"First Eagle Investment Management, LLC","position":1,"cik":"0001325447","reported_name":"First Eagle Investment Management, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":154711,"kind":"organization","name":"21 APRIL FUND, LTD.","position":2,"cik":"0001459708","reported_name":"21 APRIL FUND, LTD.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":156514,"kind":"organization","name":"First Eagle Value in Biotechnology Master Fund, Ltd.","position":3,"cik":"0001457518","reported_name":"First Eagle Value in Biotechnology Master Fund, Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":93499,"kind":"organization","name":"First Eagle Holdings, Inc.","position":4,"cik":"0001637141","reported_name":"First Eagle Holdings, Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2018-02-01T14:18:48.000Z","date":"2018-01-31","kind":"purchase","acquired":true,"shares":42000,"price":6.8451,"value":287494.2,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"Represents 2,677,118, 299,662 and 1,501,140 shares held directly by 21 April Ltd., FEVIBM and the Separately Managed Accounts, respectively. FEHI disclaims Section 16 beneficial ownership of the shares held directly by the Funds except to the extent, if any, of its pecuniary interest therein, and this report shall not be deemed an admission that FEHI is the Section 16 beneficial owner of any such securities."}],"balance_after":4477920,"source":{"system":"sec-edgar","filing":"0001140361-18-004372","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1001902/000114036118004372/doc1.xml","form_type":"4"}},{"id":4082410,"issuer":{"id":81388,"kind":"organization","name":"INTEVAC INC","symbol":"IVAC"},"owners":[{"id":50349,"kind":"organization","name":"First Eagle Investment Management, LLC","position":1,"cik":"0001325447","reported_name":"First Eagle Investment Management, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":154711,"kind":"organization","name":"21 APRIL FUND, LTD.","position":2,"cik":"0001459708","reported_name":"21 APRIL FUND, LTD.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":156514,"kind":"organization","name":"First Eagle Value in Biotechnology Master Fund, Ltd.","position":3,"cik":"0001457518","reported_name":"First Eagle Value in Biotechnology Master Fund, Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":93499,"kind":"organization","name":"First Eagle Holdings, Inc.","position":4,"cik":"0001637141","reported_name":"First Eagle Holdings, Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2018-02-01T14:18:48.000Z","date":"2018-01-31","kind":"purchase","acquired":true,"shares":19485,"price":6.799,"value":132478.515,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"Represents 2,640,074, 299,662 and 1,496,184 shares held directly by 21 April Ltd., FEVIBM and the Separately Managed Accounts, respectively. FEHI disclaims Section 16 beneficial ownership of the shares held directly by the Funds except to the extent, if any, of its pecuniary interest therein, and this report shall not be deemed an admission that FEHI is the Section 16 beneficial owner of any such securities."}],"balance_after":4435920,"source":{"system":"sec-edgar","filing":"0001140361-18-004372","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1001902/000114036118004372/doc1.xml","form_type":"4"}},{"id":4082409,"issuer":{"id":81388,"kind":"organization","name":"INTEVAC INC","symbol":"IVAC"},"owners":[{"id":50349,"kind":"organization","name":"First Eagle Investment Management, LLC","position":1,"cik":"0001325447","reported_name":"First Eagle Investment Management, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":154711,"kind":"organization","name":"21 APRIL FUND, LTD.","position":2,"cik":"0001459708","reported_name":"21 APRIL FUND, LTD.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":156514,"kind":"organization","name":"First Eagle Value in Biotechnology Master Fund, Ltd.","position":3,"cik":"0001457518","reported_name":"First Eagle Value in Biotechnology Master Fund, Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":93499,"kind":"organization","name":"First Eagle Holdings, Inc.","position":4,"cik":"0001637141","reported_name":"First Eagle Holdings, Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2018-02-01T14:18:48.000Z","date":"2018-01-30","kind":"purchase","acquired":true,"shares":13400,"price":6.825,"value":91455.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Represents 2,622,888, 299,662 and 1,493,885 shares held directly by 21 April Ltd., FEVIBM and the Separately Managed Accounts, respectively. FEHI disclaims Section 16 beneficial ownership of the shares held directly by the Funds except to the extent, if any, of its pecuniary interest therein, and this report shall not be deemed an admission that FEHI is the Section 16 beneficial owner of any such securities."}],"balance_after":4416435,"source":{"system":"sec-edgar","filing":"0001140361-18-004372","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1001902/000114036118004372/doc1.xml","form_type":"4"}},{"id":4082408,"issuer":{"id":81388,"kind":"organization","name":"INTEVAC INC","symbol":"IVAC"},"owners":[{"id":50349,"kind":"organization","name":"First Eagle Investment Management, LLC","position":1,"cik":"0001325447","reported_name":"First Eagle Investment Management, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":154711,"kind":"organization","name":"21 APRIL FUND, LTD.","position":2,"cik":"0001459708","reported_name":"21 APRIL FUND, LTD.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":156514,"kind":"organization","name":"First Eagle Value in Biotechnology Master Fund, Ltd.","position":3,"cik":"0001457518","reported_name":"First Eagle Value in Biotechnology Master Fund, Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":93499,"kind":"organization","name":"First Eagle Holdings, Inc.","position":4,"cik":"0001637141","reported_name":"First Eagle Holdings, Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2018-02-01T14:18:48.000Z","date":"2018-01-30","kind":"purchase","acquired":true,"shares":13298,"price":6.7083,"value":89206.9734,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"This Form 4 is filed by 21 April Ltd. (\"April Ltd.\"), First Eagle Investment Management, LLC (\"FEIM\"), First Eagle Value in Biotechnology Master Fund, Ltd. (\"FEVIBM\") and First Eagle Holdings, Inc. (\"FEHI\" and, collectively with April Ltd., FEIM and FEVIBM, the \"Entities\"). The Entities disclaim status as a \"group\" for purposes of this Form 4."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The shares of Common Stock reported herein are indirectly beneficially owned by FEHI and FEIM, a Delaware limited liability company and an investment adviser registered under the Investment Advisers Act of 1940. FEIM is (i) the registered investment adviser to FEVIBM as well as to April Ltd. (collectively, the \"Funds\"), (ii) a subsidiary of FEHI and (iii) investment adviser to certain separately managed accounts which, together with certain separate accounts managed by Michael M. Kellen in his individual capacity holding shares reported by FEIM for which FEIM disclaims beneficial ownership are defined herein as the \"Separately Managed Accounts\". FEHI disclaims Section 16 beneficial ownership of the shares held directly by the Funds except to the extent, if any, of its pecuniary interest therein, and this report shall not be deemed an admission that FEHI is the Section 16 beneficial owner of any such securities."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Represents 2,611,069, 299,662 and 1,492,304 shares held directly by 21 April Ltd., FEVIBM and the Separately Managed Accounts, respectively. FEHI disclaims Section 16 beneficial ownership of the shares held directly by the Funds except to the extent, if any, of its pecuniary interest therein, and this report shall not be deemed an admission that FEHI is the Section 16 beneficial owner of any such securities."}],"balance_after":4403035,"source":{"system":"sec-edgar","filing":"0001140361-18-004372","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1001902/000114036118004372/doc1.xml","form_type":"4"}},{"id":4121824,"issuer":{"id":7037,"kind":"organization","name":"INVE Technologies, Inc.","symbol":"INVE"},"owners":[{"id":154711,"kind":"organization","name":"21 APRIL FUND, LTD.","position":1,"cik":"0001459708","reported_name":"21 APRIL FUND, LTD.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":50349,"kind":"organization","name":"First Eagle Investment Management, LLC","position":2,"cik":"0001325447","reported_name":"First Eagle Investment Management, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":93499,"kind":"organization","name":"First Eagle Holdings, Inc.","position":3,"cik":"0001637141","reported_name":"First Eagle Holdings, Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series B Non-Voting Convertible Preferred Stock","published_at":"2017-12-26T22:26:59.000Z","date":"2017-12-21","kind":"purchase","acquired":true,"shares":611539,"price":4,"value":2446156.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"See Exhibit 99.1, Note 2."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"See Exhibit 99.1, Note 2."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"See Exhibit 99.1, Note 2."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F2","text":"See Exhibit 99.1, Note 2."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"See Exhibit 99.1, Note 4."}],"balance_after":611539,"derivative":{"exercise_price":4,"exercise_date":"2023-12-21","underlying":"Common Stock","underlying_shares":611539},"source":{"system":"sec-edgar","filing":"0001140361-17-047404","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1036044/000114036117047404/doc1.xml","form_type":"4"}},{"id":4121823,"issuer":{"id":7037,"kind":"organization","name":"INVE Technologies, Inc.","symbol":"INVE"},"owners":[{"id":154711,"kind":"organization","name":"21 APRIL FUND, LTD.","position":1,"cik":"0001459708","reported_name":"21 APRIL FUND, LTD.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":50349,"kind":"organization","name":"First Eagle Investment Management, LLC","position":2,"cik":"0001325447","reported_name":"First Eagle Investment Management, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":93499,"kind":"organization","name":"First Eagle Holdings, Inc.","position":3,"cik":"0001637141","reported_name":"First Eagle Holdings, Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series B Non-Voting Convertible Preferred Stock","published_at":"2017-12-26T22:26:59.000Z","date":"2017-12-21","kind":"purchase","acquired":true,"shares":2388461,"price":4,"value":9553844.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"See Exhibit 99.1, Note 1."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"See Exhibit 99.1, Note 2."},{"field":"shares","element":"transactionShares","label":"F3","text":"See Exhibit 99.1, Note 3."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"See Exhibit 99.1, Note 2."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"See Exhibit 99.1, Note 2."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F2","text":"See Exhibit 99.1, Note 2."}],"balance_after":2388461,"derivative":{"exercise_price":4,"exercise_date":"2023-12-21","underlying":"Common Stock","underlying_shares":2388461},"source":{"system":"sec-edgar","filing":"0001140361-17-047404","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1036044/000114036117047404/doc1.xml","form_type":"4"}},{"id":4327048,"issuer":{"id":81388,"kind":"organization","name":"INTEVAC INC","symbol":"IVAC"},"owners":[{"id":50349,"kind":"organization","name":"First Eagle Investment Management, LLC","position":1,"cik":"0001325447","reported_name":"First Eagle Investment Management, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":154711,"kind":"organization","name":"21 APRIL FUND, LTD.","position":2,"cik":"0001459708","reported_name":"21 APRIL FUND, LTD.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":156514,"kind":"organization","name":"First Eagle Value in Biotechnology Master Fund, Ltd.","position":3,"cik":"0001457518","reported_name":"First Eagle Value in Biotechnology Master Fund, Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":93499,"kind":"organization","name":"First Eagle Holdings, Inc.","position":4,"cik":"0001637141","reported_name":"First Eagle Holdings, Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2017-05-10T09:36:10.000Z","date":"2017-05-09","kind":"sale","acquired":false,"shares":19075,"price":13.0434,"value":248802.855,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"These shares are indirectly beneficially owned by certain Separately Managed Accounts."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F7","text":"Represents 2,599,340, 299,662 and 1,490,735 shares held directly by 21 April Ltd., FEVIBM and the Separately Managed Accounts, respectively. FEHI disclaims Section 16 beneficial ownership of the shares held directly by the Funds except to the extent, if any, of its pecuniary interest therein, and this report shall not be deemed an admission that FEHI is the Section 16 beneficial owner of any such securities."}],"balance_after":4389737,"source":{"system":"sec-edgar","filing":"0001140361-17-019221","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1001902/000114036117019221/doc1.xml","form_type":"4"}},{"id":4327047,"issuer":{"id":81388,"kind":"organization","name":"INTEVAC INC","symbol":"IVAC"},"owners":[{"id":50349,"kind":"organization","name":"First Eagle Investment Management, LLC","position":1,"cik":"0001325447","reported_name":"First Eagle Investment Management, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":154711,"kind":"organization","name":"21 APRIL FUND, LTD.","position":2,"cik":"0001459708","reported_name":"21 APRIL FUND, LTD.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":156514,"kind":"organization","name":"First Eagle Value in Biotechnology Master Fund, Ltd.","position":3,"cik":"0001457518","reported_name":"First Eagle Value in Biotechnology Master Fund, Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":93499,"kind":"organization","name":"First Eagle Holdings, Inc.","position":4,"cik":"0001637141","reported_name":"First Eagle Holdings, Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2017-05-10T09:36:10.000Z","date":"2017-05-09","kind":"sale","acquired":false,"shares":13505,"price":13.0434,"value":176151.117,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"Represents 2,599,340, 299,662 and 1,509,810 shares held directly by 21 April Ltd., FEVIBM and the Separately Managed Accounts, respectively. FEHI disclaims Section 16 beneficial ownership of the shares held directly by the Funds except to the extent, if any, of its pecuniary interest therein, and this report shall not be deemed an admission that FEHI is the Section 16 beneficial owner of any such securities."}],"balance_after":4408812,"source":{"system":"sec-edgar","filing":"0001140361-17-019221","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1001902/000114036117019221/doc1.xml","form_type":"4"}},{"id":4327046,"issuer":{"id":81388,"kind":"organization","name":"INTEVAC INC","symbol":"IVAC"},"owners":[{"id":50349,"kind":"organization","name":"First Eagle Investment Management, LLC","position":1,"cik":"0001325447","reported_name":"First Eagle Investment Management, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":154711,"kind":"organization","name":"21 APRIL FUND, LTD.","position":2,"cik":"0001459708","reported_name":"21 APRIL FUND, LTD.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":156514,"kind":"organization","name":"First Eagle Value in Biotechnology Master Fund, Ltd.","position":3,"cik":"0001457518","reported_name":"First Eagle Value in Biotechnology Master Fund, Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":93499,"kind":"organization","name":"First Eagle Holdings, Inc.","position":4,"cik":"0001637141","reported_name":"First Eagle Holdings, Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2017-05-10T09:36:10.000Z","date":"2017-05-08","kind":"sale","acquired":false,"shares":20477,"price":13,"value":266201.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"These shares are indirectly beneficially owned by certain Separately Managed Accounts."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"Represents 2,599,340, 313,167 and 1,509,810 shares held directly by 21 April Ltd., FEVIBM and the Separately Managed Accounts, respectively. FEHI disclaims Section 16 beneficial ownership of the shares held directly by the Funds except to the extent, if any, of its pecuniary interest therein, and this report shall not be deemed an admission that FEHI is the Section 16 beneficial owner of any such securities."}],"balance_after":4422317,"source":{"system":"sec-edgar","filing":"0001140361-17-019221","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1001902/000114036117019221/doc1.xml","form_type":"4"}},{"id":4327045,"issuer":{"id":81388,"kind":"organization","name":"INTEVAC INC","symbol":"IVAC"},"owners":[{"id":50349,"kind":"organization","name":"First Eagle Investment Management, LLC","position":1,"cik":"0001325447","reported_name":"First Eagle Investment Management, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":154711,"kind":"organization","name":"21 APRIL FUND, LTD.","position":2,"cik":"0001459708","reported_name":"21 APRIL FUND, LTD.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":156514,"kind":"organization","name":"First Eagle Value in Biotechnology Master Fund, Ltd.","position":3,"cik":"0001457518","reported_name":"First Eagle Value in Biotechnology Master Fund, Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":93499,"kind":"organization","name":"First Eagle Holdings, Inc.","position":4,"cik":"0001637141","reported_name":"First Eagle Holdings, Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2017-05-10T09:36:10.000Z","date":"2017-05-08","kind":"sale","acquired":false,"shares":14497,"price":13,"value":188461.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"This Form 4 is filed by 21 April Ltd. (\"April Ltd.\"), First Eagle Investment Management, LLC (\"FEIM\"), First Eagle Value in Biotechnology Master Fund, Ltd. (\"FEVIBM\") and First Eagle Holdings, Inc. (\"FEHI\" and, collectively with April Ltd., FEIM and FEVIBM, the \"Entities\"). The Entities disclaim status as a \"group\" for purposes of this Form 4."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The shares of Common Stock reported herein are indirectly beneficially owned by FEHI and FEIM, a Delaware limited liability company and an investment adviser registered under the Investment Advisers Act of 1940. FEIM is (i) the registered investment adviser to FEVIBM as well as to April Ltd. (collectively, the \"Funds\"), (ii) a subsidiary of FEHI and (iii) investment adviser to certain separately managed accounts which, together with certain separate accounts managed by Michael M. Kellen in his individual capacity holding shares reported by FEIM for which FEIM disclaims beneficial ownership are defined herein as the \"Separately Managed Accounts\". FEHI disclaims Section 16 beneficial ownership of the shares held directly by the Funds except to the extent, if any, of its pecuniary interest therein, and this report shall not be deemed an admission that FEHI is the Section 16 beneficial owner of any such securities."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Represents 2,599,340, 313,167 and 1,530,287 shares held directly by 21 April Ltd., FEVIBM and the Separately Managed Accounts, respectively. FEHI disclaims Section 16 beneficial ownership of the shares held directly by the Funds except to the extent, if any, of its pecuniary interest therein, and this report shall not be deemed an admission that FEHI is the Section 16 beneficial owner of any such securities."}],"balance_after":4442794,"source":{"system":"sec-edgar","filing":"0001140361-17-019221","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1001902/000114036117019221/doc1.xml","form_type":"4"}},{"id":4333792,"issuer":{"id":81388,"kind":"organization","name":"INTEVAC INC","symbol":"IVAC"},"owners":[{"id":50349,"kind":"organization","name":"First Eagle Investment Management, LLC","position":1,"cik":"0001325447","reported_name":"First Eagle Investment Management, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":154711,"kind":"organization","name":"21 APRIL FUND, LTD.","position":2,"cik":"0001459708","reported_name":"21 APRIL FUND, LTD.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":156514,"kind":"organization","name":"First Eagle Value in Biotechnology Master Fund, Ltd.","position":3,"cik":"0001457518","reported_name":"First Eagle Value in Biotechnology Master Fund, Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":93499,"kind":"organization","name":"First Eagle Holdings, Inc.","position":4,"cik":"0001637141","reported_name":"First Eagle Holdings, Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2017-05-04T11:47:07.000Z","date":"2017-05-03","kind":"sale","acquired":false,"shares":3337,"price":13,"value":43381.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"These shares are indirectly beneficially owned by certain Separately Managed Accounts."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F7","text":"Represents 2,599,340, 327,664 and 1,530,287 shares held directly by 21 April Ltd., FEVIBM and the Separately Managed Accounts, respectively. FEHI disclaims Section 16 beneficial ownership of the shares held directly by the Funds except to the extent, if any, of its pecuniary interest therein, and this report shall not be deemed an admission that FEHI is the Section 16 beneficial owner of any such securities."}],"balance_after":4457291,"source":{"system":"sec-edgar","filing":"0001140361-17-018386","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1001902/000114036117018386/doc1.xml","form_type":"4"}},{"id":4333791,"issuer":{"id":81388,"kind":"organization","name":"INTEVAC INC","symbol":"IVAC"},"owners":[{"id":50349,"kind":"organization","name":"First Eagle Investment Management, LLC","position":1,"cik":"0001325447","reported_name":"First Eagle Investment Management, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":154711,"kind":"organization","name":"21 APRIL FUND, LTD.","position":2,"cik":"0001459708","reported_name":"21 APRIL FUND, LTD.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":156514,"kind":"organization","name":"First Eagle Value in Biotechnology Master Fund, Ltd.","position":3,"cik":"0001457518","reported_name":"First Eagle Value in Biotechnology Master Fund, Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":93499,"kind":"organization","name":"First Eagle Holdings, Inc.","position":4,"cik":"0001637141","reported_name":"First Eagle Holdings, Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2017-05-04T11:47:07.000Z","date":"2017-05-03","kind":"sale","acquired":false,"shares":2363,"price":13,"value":30719.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"Represents 2,599,340, 327,664 and 1,533,624 shares held directly by 21 April Ltd., FEVIBM and the Separately Managed Accounts, respectively. FEHI disclaims Section 16 beneficial ownership of the shares held directly by the Funds except to the extent, if any, of its pecuniary interest therein, and this report shall not be deemed an admission that FEHI is the Section 16 beneficial owner of any such securities."}],"balance_after":4460628,"source":{"system":"sec-edgar","filing":"0001140361-17-018386","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1001902/000114036117018386/doc1.xml","form_type":"4"}},{"id":4333790,"issuer":{"id":81388,"kind":"organization","name":"INTEVAC INC","symbol":"IVAC"},"owners":[{"id":50349,"kind":"organization","name":"First Eagle Investment Management, LLC","position":1,"cik":"0001325447","reported_name":"First Eagle Investment Management, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":154711,"kind":"organization","name":"21 APRIL FUND, LTD.","position":2,"cik":"0001459708","reported_name":"21 APRIL FUND, LTD.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":156514,"kind":"organization","name":"First Eagle Value in Biotechnology Master Fund, Ltd.","position":3,"cik":"0001457518","reported_name":"First Eagle Value in Biotechnology Master Fund, Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":93499,"kind":"organization","name":"First Eagle Holdings, Inc.","position":4,"cik":"0001637141","reported_name":"First Eagle Holdings, Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2017-05-04T11:47:07.000Z","date":"2017-05-02","kind":"sale","acquired":false,"shares":18435,"price":13.3262,"value":245668.497,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"These shares are indirectly beneficially owned by certain Separately Managed Accounts."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"Represents 2,599,340, 330,027 and 1,533,624 shares held directly by 21 April Ltd., FEVIBM and the Separately Managed Accounts, respectively. FEHI disclaims Section 16 beneficial ownership of the shares held directly by the Funds except to the extent, if any, of its pecuniary interest therein, and this report shall not be deemed an admission that FEHI is the Section 16 beneficial owner of any such securities."}],"balance_after":4462991,"source":{"system":"sec-edgar","filing":"0001140361-17-018386","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1001902/000114036117018386/doc1.xml","form_type":"4"}},{"id":4333789,"issuer":{"id":81388,"kind":"organization","name":"INTEVAC INC","symbol":"IVAC"},"owners":[{"id":50349,"kind":"organization","name":"First Eagle Investment Management, LLC","position":1,"cik":"0001325447","reported_name":"First Eagle Investment Management, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":154711,"kind":"organization","name":"21 APRIL FUND, LTD.","position":2,"cik":"0001459708","reported_name":"21 APRIL FUND, LTD.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":156514,"kind":"organization","name":"First Eagle Value in Biotechnology Master Fund, Ltd.","position":3,"cik":"0001457518","reported_name":"First Eagle Value in Biotechnology Master Fund, Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":93499,"kind":"organization","name":"First Eagle Holdings, Inc.","position":4,"cik":"0001637141","reported_name":"First Eagle Holdings, Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2017-05-04T11:47:07.000Z","date":"2017-05-02","kind":"sale","acquired":false,"shares":13052,"price":13.3262,"value":173933.5624,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"This Form 4 is filed by 21 April Ltd. (\"April Ltd.\"), First Eagle Investment Management, LLC (\"FEIM\"), First Eagle Value in Biotechnology Master Fund, Ltd. (\"FEVIBM\") and First Eagle Holdings, Inc. (\"FEHI\" and, collectively with April Ltd., FEIM and FEVIBM, the \"Entities\"). The Entities disclaim status as a \"group\" for purposes of this Form 4."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The shares of Common Stock reported herein are indirectly beneficially owned by FEHI and FEIM, a Delaware limited liability company and an investment adviser registered under the Investment Advisers Act of 1940. FEIM is (i) the registered investment adviser to FEVIBM as well as to April Ltd. (collectively, the \"Funds\"), (ii) a subsidiary of FEHI and (iii) investment adviser to certain separately managed accounts which, together with certain separate accounts managed by Michael M. Kellen in his individual capacity holding shares reported by FEIM for which FEIM disclaims beneficial ownership are defined herein as the \"Separately Managed Accounts\". FEHI disclaims Section 16 beneficial ownership of the shares held directly by the Funds except to the extent, if any, of its pecuniary interest therein, and this report shall not be deemed an admission that FEHI is the Section 16 beneficial owner of any such securities."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Represents 2,599,340, 330,027 and 1,552,059 shares held directly by 21 April Ltd., FEVIBM and the Separately Managed Accounts, respectively. FEHI disclaims Section 16 beneficial ownership of the shares held directly by the Funds except to the extent, if any, of its pecuniary interest therein, and this report shall not be deemed an admission that FEHI is the Section 16 beneficial owner of any such securities."}],"balance_after":4481426,"source":{"system":"sec-edgar","filing":"0001140361-17-018386","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1001902/000114036117018386/doc1.xml","form_type":"4"}},{"id":4338692,"issuer":{"id":81388,"kind":"organization","name":"INTEVAC INC","symbol":"IVAC"},"owners":[{"id":50349,"kind":"organization","name":"First Eagle Investment Management, LLC","position":1,"cik":"0001325447","reported_name":"First Eagle Investment Management, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":154711,"kind":"organization","name":"21 APRIL FUND, LTD.","position":2,"cik":"0001459708","reported_name":"21 APRIL FUND, LTD.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":156514,"kind":"organization","name":"First Eagle Value in Biotechnology Master Fund, Ltd.","position":3,"cik":"0001457518","reported_name":"First Eagle Value in Biotechnology Master Fund, Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":93499,"kind":"organization","name":"First Eagle Holdings, Inc.","position":4,"cik":"0001637141","reported_name":"First Eagle Holdings, Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2017-05-02T11:22:00.000Z","date":"2017-05-01","kind":"sale","acquired":false,"shares":17641,"price":13,"value":229333.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"These shares are indirectly beneficially owned by certain Separately Managed Accounts."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F7","text":"Represents 2,599,340, 343,079 and 1,552,059 shares held directly by 21 April Ltd., FEVIBM and the Separately Managed Accounts, respectively. FEHI disclaims Section 16 beneficial ownership of the shares held directly by the Funds except to the extent, if any, of its pecuniary interest therein, and this report shall not be deemed an admission that FEHI is the Section 16 beneficial owner of any such securities."}],"balance_after":4494478,"source":{"system":"sec-edgar","filing":"0001140361-17-017790","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1001902/000114036117017790/doc1.xml","form_type":"4"}},{"id":4338691,"issuer":{"id":81388,"kind":"organization","name":"INTEVAC INC","symbol":"IVAC"},"owners":[{"id":50349,"kind":"organization","name":"First Eagle Investment Management, LLC","position":1,"cik":"0001325447","reported_name":"First Eagle Investment Management, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":154711,"kind":"organization","name":"21 APRIL FUND, LTD.","position":2,"cik":"0001459708","reported_name":"21 APRIL FUND, LTD.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":156514,"kind":"organization","name":"First Eagle Value in Biotechnology Master Fund, Ltd.","position":3,"cik":"0001457518","reported_name":"First Eagle Value in Biotechnology Master Fund, Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":93499,"kind":"organization","name":"First Eagle Holdings, Inc.","position":4,"cik":"0001637141","reported_name":"First Eagle Holdings, Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2017-05-02T11:22:00.000Z","date":"2017-05-01","kind":"sale","acquired":false,"shares":12490,"price":13,"value":162370.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"Represents 2,599,340, 343,079 and 1,569,700 shares held directly by 21 April Ltd., FEVIBM and the Separately Managed Accounts, respectively. FEHI disclaims Section 16 beneficial ownership of the shares held directly by the Funds except to the extent, if any, of its pecuniary interest therein, and this report shall not be deemed an admission that FEHI is the Section 16 beneficial owner of any such securities."}],"balance_after":4512119,"source":{"system":"sec-edgar","filing":"0001140361-17-017790","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1001902/000114036117017790/doc1.xml","form_type":"4"}},{"id":4338690,"issuer":{"id":81388,"kind":"organization","name":"INTEVAC INC","symbol":"IVAC"},"owners":[{"id":50349,"kind":"organization","name":"First Eagle Investment Management, LLC","position":1,"cik":"0001325447","reported_name":"First Eagle Investment Management, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":154711,"kind":"organization","name":"21 APRIL FUND, LTD.","position":2,"cik":"0001459708","reported_name":"21 APRIL FUND, LTD.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":156514,"kind":"organization","name":"First Eagle Value in Biotechnology Master Fund, Ltd.","position":3,"cik":"0001457518","reported_name":"First Eagle Value in Biotechnology Master Fund, Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":93499,"kind":"organization","name":"First Eagle Holdings, Inc.","position":4,"cik":"0001637141","reported_name":"First Eagle Holdings, Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2017-05-02T11:22:00.000Z","date":"2017-04-28","kind":"sale","acquired":false,"shares":1815,"price":13.0169,"value":23625.6735,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"These shares are indirectly beneficially owned by certain Separately Managed Accounts."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"Represents 2,599,340, 355,569 and 1,569,700 shares held directly by 21 April Ltd., FEVIBM and the Separately Managed Accounts, respectively. FEHI disclaims Section 16 beneficial ownership of the shares held directly by the Funds except to the extent, if any, of its pecuniary interest therein, and this report shall not be deemed an admission that FEHI is the Section 16 beneficial owner of any such securities."}],"balance_after":4524609,"source":{"system":"sec-edgar","filing":"0001140361-17-017790","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1001902/000114036117017790/doc1.xml","form_type":"4"}},{"id":4338689,"issuer":{"id":81388,"kind":"organization","name":"INTEVAC INC","symbol":"IVAC"},"owners":[{"id":50349,"kind":"organization","name":"First Eagle Investment Management, LLC","position":1,"cik":"0001325447","reported_name":"First Eagle Investment Management, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":154711,"kind":"organization","name":"21 APRIL FUND, LTD.","position":2,"cik":"0001459708","reported_name":"21 APRIL FUND, LTD.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":156514,"kind":"organization","name":"First Eagle Value in Biotechnology Master Fund, Ltd.","position":3,"cik":"0001457518","reported_name":"First Eagle Value in Biotechnology Master Fund, Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":93499,"kind":"organization","name":"First Eagle Holdings, Inc.","position":4,"cik":"0001637141","reported_name":"First Eagle Holdings, Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2017-05-02T11:22:00.000Z","date":"2017-04-28","kind":"sale","acquired":false,"shares":1285,"price":13.0169,"value":16726.7165,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"This Form 4 is filed by 21 April Ltd. (\"April Ltd.\"), First Eagle Investment Management, LLC (\"FEIM\"), First Eagle Value in Biotechnology Master Fund, Ltd. (\"FEVIBM\") and First Eagle Holdings, Inc. (\"FEHI\" and, collectively with April Ltd., FEIM and FEVIBM, the \"Entities\"). The Entities disclaim status as a \"group\" for purposes of this Form 4."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The shares of Common Stock reported herein are indirectly beneficially owned by FEHI and FEIM, a Delaware limited liability company and an investment adviser registered under the Investment Advisers Act of 1940. FEIM is (i) the registered investment adviser to FEVIBM as well as to April Ltd. (collectively, the \"Funds\"), (ii) a subsidiary of FEHI and (iii) investment adviser to certain separately managed accounts which, together with certain separate accounts managed by Michael M. Kellen in his individual capacity holding shares reported by FEIM for which FEIM disclaims beneficial ownership are defined herein as the \"Separately Managed Accounts\". FEHI disclaims Section 16 beneficial ownership of the shares held directly by the Funds except to the extent, if any, of its pecuniary interest therein, and this report shall not be deemed an admission that FEHI is the Section 16 beneficial owner of any such securities."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Represents 2,599,340, 355,569 and 1,571,515 shares held directly by 21 April Ltd., FEVIBM and the Separately Managed Accounts, respectively. FEHI disclaims Section 16 beneficial ownership of the shares held directly by the Funds except to the extent, if any, of its pecuniary interest therein, and this report shall not be deemed an admission that FEHI is the Section 16 beneficial owner of any such securities."}],"balance_after":4526424,"source":{"system":"sec-edgar","filing":"0001140361-17-017790","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1001902/000114036117017790/doc1.xml","form_type":"4"}},{"id":4342506,"issuer":{"id":81388,"kind":"organization","name":"INTEVAC INC","symbol":"IVAC"},"owners":[{"id":50349,"kind":"organization","name":"First Eagle Investment Management, LLC","position":1,"cik":"0001325447","reported_name":"First Eagle Investment Management, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":154711,"kind":"organization","name":"21 APRIL FUND, LTD.","position":2,"cik":"0001459708","reported_name":"21 APRIL FUND, LTD.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":156514,"kind":"organization","name":"First Eagle Value in Biotechnology Master Fund, Ltd.","position":3,"cik":"0001457518","reported_name":"First Eagle Value in Biotechnology Master Fund, Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":93499,"kind":"organization","name":"First Eagle Holdings, Inc.","position":4,"cik":"0001637141","reported_name":"First Eagle Holdings, Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2017-04-28T10:04:25.000Z","date":"2017-04-27","kind":"sale","acquired":false,"shares":31138,"price":13.0087,"value":405064.9006,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"These shares are indirectly beneficially owned by certain Separately Managed Accounts."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F7","text":"Represents 2,599,340, 356,854 and 1,571,515 shares held directly by 21 April Ltd., FEVIBM and the Separately Managed Accounts, respectively. FEHI disclaims Section 16 beneficial ownership of the shares held directly by the Funds except to the extent, if any, of its pecuniary interest therein, and this report shall not be deemed an admission that FEHI is the Section 16 beneficial owner of any such securities."}],"balance_after":4527709,"source":{"system":"sec-edgar","filing":"0001140361-17-017253","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1001902/000114036117017253/doc1.xml","form_type":"4"}},{"id":4342505,"issuer":{"id":81388,"kind":"organization","name":"INTEVAC INC","symbol":"IVAC"},"owners":[{"id":50349,"kind":"organization","name":"First Eagle Investment Management, LLC","position":1,"cik":"0001325447","reported_name":"First Eagle Investment Management, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":154711,"kind":"organization","name":"21 APRIL FUND, LTD.","position":2,"cik":"0001459708","reported_name":"21 APRIL FUND, LTD.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":156514,"kind":"organization","name":"First Eagle Value in Biotechnology Master Fund, Ltd.","position":3,"cik":"0001457518","reported_name":"First Eagle Value in Biotechnology Master Fund, Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":93499,"kind":"organization","name":"First Eagle Holdings, Inc.","position":4,"cik":"0001637141","reported_name":"First Eagle Holdings, Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2017-04-28T10:04:25.000Z","date":"2017-04-27","kind":"sale","acquired":false,"shares":22047,"price":13.0087,"value":286802.8089,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The shares of Common Stock reported herein are indirectly beneficially owned by FEHI and FEIM, a Delaware limited liability company and an investment adviser registered under the Investment Advisers Act of 1940. FEIM is (i) the registered investment adviser to FEVIBM as well as to April Ltd. (collectively, the \"Funds\"), (ii) a subsidiary of FEHI and (iii) investment adviser to certain separately managed accounts which, together with certain separate accounts managed by Michael M. Kellen in his individual capacity holding shares reported by FEIM for which FEIM disclaims beneficial ownership are defined herein as the \"Separately Managed Accounts\". FEHI disclaims Section 16 beneficial ownership of the shares held directly by the Funds except to the extent, if any, of its pecuniary interest therein, and this report shall not be deemed an admission that FEHI is the Section 16 beneficial owner of any such securities."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"Represents 2,599,340, 356,854 and 1,602,653 shares held directly by 21 April Ltd., FEVIBM and the Separately Managed Accounts, respectively. FEHI disclaims Section 16 beneficial ownership of the shares held directly by the Funds except to the extent, if any, of its pecuniary interest therein, and this report shall not be deemed an admission that FEHI is the Section 16 beneficial owner of any such securities."}],"balance_after":4558847,"source":{"system":"sec-edgar","filing":"0001140361-17-017253","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1001902/000114036117017253/doc1.xml","form_type":"4"}},{"id":4342504,"issuer":{"id":81388,"kind":"organization","name":"INTEVAC INC","symbol":"IVAC"},"owners":[{"id":50349,"kind":"organization","name":"First Eagle Investment Management, LLC","position":1,"cik":"0001325447","reported_name":"First Eagle Investment Management, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":154711,"kind":"organization","name":"21 APRIL FUND, LTD.","position":2,"cik":"0001459708","reported_name":"21 APRIL FUND, LTD.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":156514,"kind":"organization","name":"First Eagle Value in Biotechnology Master Fund, Ltd.","position":3,"cik":"0001457518","reported_name":"First Eagle Value in Biotechnology Master Fund, Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":93499,"kind":"organization","name":"First Eagle Holdings, Inc.","position":4,"cik":"0001637141","reported_name":"First Eagle Holdings, Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2017-04-28T10:04:25.000Z","date":"2017-04-26","kind":"sale","acquired":false,"shares":37254,"price":13.0261,"value":485274.3294,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"These shares are indirectly beneficially owned by certain Separately Managed Accounts."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"Represents 2,599,340, 378,901 and 1,602,653 shares held directly by 21 April Ltd., FEVIBM and the Separately Managed Accounts, respectively. FEHI disclaims Section 16 beneficial ownership of the shares held directly by the Funds except to the extent, if any, of its pecuniary interest therein, and this report shall not be deemed an admission that FEHI is the Section 16 beneficial owner of any such securities."}],"balance_after":4580894,"source":{"system":"sec-edgar","filing":"0001140361-17-017253","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1001902/000114036117017253/doc1.xml","form_type":"4"}},{"id":4342503,"issuer":{"id":81388,"kind":"organization","name":"INTEVAC INC","symbol":"IVAC"},"owners":[{"id":50349,"kind":"organization","name":"First Eagle Investment Management, LLC","position":1,"cik":"0001325447","reported_name":"First Eagle Investment Management, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":154711,"kind":"organization","name":"21 APRIL FUND, LTD.","position":2,"cik":"0001459708","reported_name":"21 APRIL FUND, LTD.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":156514,"kind":"organization","name":"First Eagle Value in Biotechnology Master Fund, Ltd.","position":3,"cik":"0001457518","reported_name":"First Eagle Value in Biotechnology Master Fund, Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":93499,"kind":"organization","name":"First Eagle Holdings, Inc.","position":4,"cik":"0001637141","reported_name":"First Eagle Holdings, Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2017-04-28T10:04:25.000Z","date":"2017-04-26","kind":"sale","acquired":false,"shares":26376,"price":13.0261,"value":343576.4136,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"This Form 4 is filed by 21 April Ltd. (\"April Ltd.\"), First Eagle Investment Management, LLC (\"FEIM\"), First Eagle Value in Biotechnology Master Fund, Ltd. (\"FEVIBM\") and First Eagle Holdings, Inc. (\"FEHI\" and, collectively with April Ltd., FEIM and FEVIBM, the \"Entities\"). The Entities disclaim status as a \"group\" for purposes of this Form 4."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The shares of Common Stock reported herein are indirectly beneficially owned by FEHI and FEIM, a Delaware limited liability company and an investment adviser registered under the Investment Advisers Act of 1940. FEIM is (i) the registered investment adviser to FEVIBM as well as to April Ltd. (collectively, the \"Funds\"), (ii) a subsidiary of FEHI and (iii) investment adviser to certain separately managed accounts which, together with certain separate accounts managed by Michael M. Kellen in his individual capacity holding shares reported by FEIM for which FEIM disclaims beneficial ownership are defined herein as the \"Separately Managed Accounts\". FEHI disclaims Section 16 beneficial ownership of the shares held directly by the Funds except to the extent, if any, of its pecuniary interest therein, and this report shall not be deemed an admission that FEHI is the Section 16 beneficial owner of any such securities."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Represents 2,599,340, 378,901 and 1,639,907 shares held directly by 21 April Ltd., FEVIBM and the Separately Managed Accounts, respectively. FEHI disclaims Section 16 beneficial ownership of the shares held directly by the Funds except to the extent, if any, of its pecuniary interest therein, and this report shall not be deemed an admission that FEHI is the Section 16 beneficial owner of any such securities."}],"balance_after":4618148,"source":{"system":"sec-edgar","filing":"0001140361-17-017253","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1001902/000114036117017253/doc1.xml","form_type":"4"}},{"id":4344820,"issuer":{"id":81388,"kind":"organization","name":"INTEVAC INC","symbol":"IVAC"},"owners":[{"id":50349,"kind":"organization","name":"First Eagle Investment Management, LLC","position":1,"cik":"0001325447","reported_name":"First Eagle Investment Management, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":154711,"kind":"organization","name":"21 APRIL FUND, LTD.","position":2,"cik":"0001459708","reported_name":"21 APRIL FUND, LTD.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":156514,"kind":"organization","name":"First Eagle Value in Biotechnology Master Fund, Ltd.","position":3,"cik":"0001457518","reported_name":"First Eagle Value in Biotechnology Master Fund, Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":93499,"kind":"organization","name":"First Eagle Holdings, Inc.","position":4,"cik":"0001637141","reported_name":"First Eagle Holdings, Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2017-04-26T14:39:52.000Z","date":"2017-04-25","kind":"sale","acquired":false,"shares":138617,"price":13.3368,"value":1848707.2056,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F7","text":"These shares are indirectly beneficially owned by certain Separately Managed Accounts."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The shares of Common Stock reported herein are indirectly beneficially owned by FEHI and FEIM, a Delaware limited liability company and an investment adviser registered under the Investment Advisers Act of 1940. FEIM is (i) the registered investment adviser to FEVIBM as well as to April Ltd. (collectively, the \"Funds\"), (ii) a subsidiary of FEHI and (iii) investment adviser to certain separately managed accounts which, together with certain separate accounts managed by Michael M. Kellen in his individual capacity holding shares reported by FEIM for which FEIM disclaims beneficial ownership are defined herein as the \"Separately Managed Accounts\". FEHI disclaims Section 16 beneficial ownership of the shares held directly by the Funds except to the extent, if any, of its pecuniary interest therein, and this report shall not be deemed an admission that FEHI is the Section 16 beneficial owner of any such securities."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F9","text":"Represents 2,599,340, 405,277 and 1,639,907 shares held directly by 21 April Ltd., FEVIBM and the Separately Managed Accounts, respectively. FEHI disclaims Section 16 beneficial ownership of the shares held directly by the Funds except to the extent, if any, of its pecuniary interest therein, and this report shall not be deemed an admission that FEHI is the Section 16 beneficial owner of any such securities."}],"balance_after":4644524,"source":{"system":"sec-edgar","filing":"0001140361-17-016840","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1001902/000114036117016840/doc1.xml","form_type":"4"}},{"id":4344819,"issuer":{"id":81388,"kind":"organization","name":"INTEVAC INC","symbol":"IVAC"},"owners":[{"id":50349,"kind":"organization","name":"First Eagle Investment Management, LLC","position":1,"cik":"0001325447","reported_name":"First Eagle Investment Management, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":154711,"kind":"organization","name":"21 APRIL FUND, LTD.","position":2,"cik":"0001459708","reported_name":"21 APRIL FUND, LTD.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":156514,"kind":"organization","name":"First Eagle Value in Biotechnology Master Fund, Ltd.","position":3,"cik":"0001457518","reported_name":"First Eagle Value in Biotechnology Master Fund, Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":93499,"kind":"organization","name":"First Eagle Holdings, Inc.","position":4,"cik":"0001637141","reported_name":"First Eagle Holdings, Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2017-04-26T14:39:52.000Z","date":"2017-04-25","kind":"sale","acquired":false,"shares":5855,"price":13.425,"value":78603.375,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F7","text":"These shares are indirectly beneficially owned by certain Separately Managed Accounts."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The shares of Common Stock reported herein are indirectly beneficially owned by FEHI and FEIM, a Delaware limited liability company and an investment adviser registered under the Investment Advisers Act of 1940. FEIM is (i) the registered investment adviser to FEVIBM as well as to April Ltd. (collectively, the \"Funds\"), (ii) a subsidiary of FEHI and (iii) investment adviser to certain separately managed accounts which, together with certain separate accounts managed by Michael M. Kellen in his individual capacity holding shares reported by FEIM for which FEIM disclaims beneficial ownership are defined herein as the \"Separately Managed Accounts\". FEHI disclaims Section 16 beneficial ownership of the shares held directly by the Funds except to the extent, if any, of its pecuniary interest therein, and this report shall not be deemed an admission that FEHI is the Section 16 beneficial owner of any such securities."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F8","text":"Represents 2,599,340, 405,277 and 1,778,524 shares held directly by 21 April Ltd., FEVIBM and the Separately Managed Accounts, respectively. FEHI disclaims Section 16 beneficial ownership of the shares held directly by the Funds except to the extent, if any, of its pecuniary interest therein, and this report shall not be deemed an admission that FEHI is the Section 16 beneficial owner of any such securities."}],"balance_after":4783141,"source":{"system":"sec-edgar","filing":"0001140361-17-016840","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1001902/000114036117016840/doc1.xml","form_type":"4"}},{"id":4344818,"issuer":{"id":81388,"kind":"organization","name":"INTEVAC INC","symbol":"IVAC"},"owners":[{"id":50349,"kind":"organization","name":"First Eagle Investment Management, LLC","position":1,"cik":"0001325447","reported_name":"First Eagle Investment Management, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":154711,"kind":"organization","name":"21 APRIL FUND, LTD.","position":2,"cik":"0001459708","reported_name":"21 APRIL FUND, LTD.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":156514,"kind":"organization","name":"First Eagle Value in Biotechnology Master Fund, Ltd.","position":3,"cik":"0001457518","reported_name":"First Eagle Value in Biotechnology Master Fund, Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":93499,"kind":"organization","name":"First Eagle Holdings, Inc.","position":4,"cik":"0001637141","reported_name":"First Eagle Holdings, Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2017-04-26T14:39:52.000Z","date":"2017-04-25","kind":"sale","acquired":false,"shares":98143,"price":13.3368,"value":1308913.5624,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The shares of Common Stock reported herein are indirectly beneficially owned by FEHI and FEIM, a Delaware limited liability company and an investment adviser registered under the Investment Advisers Act of 1940. FEIM is (i) the registered investment adviser to FEVIBM as well as to April Ltd. (collectively, the \"Funds\"), (ii) a subsidiary of FEHI and (iii) investment adviser to certain separately managed accounts which, together with certain separate accounts managed by Michael M. Kellen in his individual capacity holding shares reported by FEIM for which FEIM disclaims beneficial ownership are defined herein as the \"Separately Managed Accounts\". FEHI disclaims Section 16 beneficial ownership of the shares held directly by the Funds except to the extent, if any, of its pecuniary interest therein, and this report shall not be deemed an admission that FEHI is the Section 16 beneficial owner of any such securities."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"Represents 2,599,340, 405,277 and 1,784,379 shares held directly by 21 April Ltd., FEVIBM and the Separately Managed Accounts, respectively. FEHI disclaims Section 16 beneficial ownership of the shares held directly by the Funds except to the extent, if any, of its pecuniary interest therein, and this report shall not be deemed an admission that FEHI is the Section 16 beneficial owner of any such securities."}],"balance_after":4788996,"source":{"system":"sec-edgar","filing":"0001140361-17-016840","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1001902/000114036117016840/doc1.xml","form_type":"4"}},{"id":4344817,"issuer":{"id":81388,"kind":"organization","name":"INTEVAC INC","symbol":"IVAC"},"owners":[{"id":50349,"kind":"organization","name":"First Eagle Investment Management, LLC","position":1,"cik":"0001325447","reported_name":"First Eagle Investment Management, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":154711,"kind":"organization","name":"21 APRIL FUND, LTD.","position":2,"cik":"0001459708","reported_name":"21 APRIL FUND, LTD.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":156514,"kind":"organization","name":"First Eagle Value in Biotechnology Master Fund, Ltd.","position":3,"cik":"0001457518","reported_name":"First Eagle Value in Biotechnology Master Fund, Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":93499,"kind":"organization","name":"First Eagle Holdings, Inc.","position":4,"cik":"0001637141","reported_name":"First Eagle Holdings, Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2017-04-26T14:39:52.000Z","date":"2017-04-25","kind":"sale","acquired":false,"shares":4145,"price":13.425,"value":55646.625,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The shares of Common Stock reported herein are indirectly beneficially owned by FEHI and FEIM, a Delaware limited liability company and an investment adviser registered under the Investment Advisers Act of 1940. FEIM is (i) the registered investment adviser to FEVIBM as well as to April Ltd. (collectively, the \"Funds\"), (ii) a subsidiary of FEHI and (iii) investment adviser to certain separately managed accounts which, together with certain separate accounts managed by Michael M. Kellen in his individual capacity holding shares reported by FEIM for which FEIM disclaims beneficial ownership are defined herein as the \"Separately Managed Accounts\". FEHI disclaims Section 16 beneficial ownership of the shares held directly by the Funds except to the extent, if any, of its pecuniary interest therein, and this report shall not be deemed an admission that FEHI is the Section 16 beneficial owner of any such securities."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"Represents 2,599,340, 503,420 and 1,784,379 shares held directly by 21 April Ltd., FEVIBM and the Separately Managed Accounts, respectively. FEHI disclaims Section 16 beneficial ownership of the shares held directly by the Funds except to the extent, if any, of its pecuniary interest therein, and this report shall not be deemed an admission that FEHI is the Section 16 beneficial owner of any such securities."}],"balance_after":4887139,"source":{"system":"sec-edgar","filing":"0001140361-17-016840","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1001902/000114036117016840/doc1.xml","form_type":"4"}},{"id":4344816,"issuer":{"id":81388,"kind":"organization","name":"INTEVAC INC","symbol":"IVAC"},"owners":[{"id":50349,"kind":"organization","name":"First Eagle Investment Management, LLC","position":1,"cik":"0001325447","reported_name":"First Eagle Investment Management, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":154711,"kind":"organization","name":"21 APRIL FUND, LTD.","position":2,"cik":"0001459708","reported_name":"21 APRIL FUND, LTD.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":156514,"kind":"organization","name":"First Eagle Value in Biotechnology Master Fund, Ltd.","position":3,"cik":"0001457518","reported_name":"First Eagle Value in Biotechnology Master Fund, Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":93499,"kind":"organization","name":"First Eagle Holdings, Inc.","position":4,"cik":"0001637141","reported_name":"First Eagle Holdings, Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2017-04-26T14:39:52.000Z","date":"2017-04-24","kind":"sale","acquired":false,"shares":10000,"price":13.65,"value":136500.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The shares of Common Stock reported herein are indirectly beneficially owned by FEHI and FEIM, a Delaware limited liability company and an investment adviser registered under the Investment Advisers Act of 1940. FEIM is (i) the registered investment adviser to FEVIBM as well as to April Ltd. (collectively, the \"Funds\"), (ii) a subsidiary of FEHI and (iii) investment adviser to certain separately managed accounts which, together with certain separate accounts managed by Michael M. Kellen in his individual capacity holding shares reported by FEIM for which FEIM disclaims beneficial ownership are defined herein as the \"Separately Managed Accounts\". FEHI disclaims Section 16 beneficial ownership of the shares held directly by the Funds except to the extent, if any, of its pecuniary interest therein, and this report shall not be deemed an admission that FEHI is the Section 16 beneficial owner of any such securities."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Represents 2,599,340, 507,565 and 1,784,379 shares held directly by 21 April Ltd., FEVIBM and the Separately Managed Accounts, respectively. FEHI disclaims Section 16 beneficial ownership of the shares held directly by the Funds except to the extent, if any, of its pecuniary interest therein, and this report shall not be deemed an admission that FEHI is the Section 16 beneficial owner of any such securities."}],"balance_after":4891284,"source":{"system":"sec-edgar","filing":"0001140361-17-016840","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1001902/000114036117016840/doc1.xml","form_type":"4"}},{"id":4344815,"issuer":{"id":81388,"kind":"organization","name":"INTEVAC INC","symbol":"IVAC"},"owners":[{"id":50349,"kind":"organization","name":"First Eagle Investment Management, LLC","position":1,"cik":"0001325447","reported_name":"First Eagle Investment Management, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":154711,"kind":"organization","name":"21 APRIL FUND, LTD.","position":2,"cik":"0001459708","reported_name":"21 APRIL FUND, LTD.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":156514,"kind":"organization","name":"First Eagle Value in Biotechnology Master Fund, Ltd.","position":3,"cik":"0001457518","reported_name":"First Eagle Value in Biotechnology Master Fund, Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":93499,"kind":"organization","name":"First Eagle Holdings, Inc.","position":4,"cik":"0001637141","reported_name":"First Eagle Holdings, Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2017-04-26T14:39:52.000Z","date":"2017-04-24","kind":"sale","acquired":false,"shares":82097,"price":13.7016,"value":1124860.2552,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"This Form 4 is filed by 21 April Ltd. (\"April Ltd.\"), First Eagle Investment Management, LLC (\"FEIM\"), First Eagle Value in Biotechnology Master Fund, Ltd. (\"FEVIBM\") and First Eagle Holdings, Inc. (\"FEHI\" and, collectively with April Ltd., FEIM and FEVIBM, the \"Entities\"). The Entities disclaim status as a \"group\" for purposes of this Form 4."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The shares of Common Stock reported herein are indirectly beneficially owned by FEHI and FEIM, a Delaware limited liability company and an investment adviser registered under the Investment Advisers Act of 1940. FEIM is (i) the registered investment adviser to FEVIBM as well as to April Ltd. (collectively, the \"Funds\"), (ii) a subsidiary of FEHI and (iii) investment adviser to certain separately managed accounts which, together with certain separate accounts managed by Michael M. Kellen in his individual capacity holding shares reported by FEIM for which FEIM disclaims beneficial ownership are defined herein as the \"Separately Managed Accounts\". FEHI disclaims Section 16 beneficial ownership of the shares held directly by the Funds except to the extent, if any, of its pecuniary interest therein, and this report shall not be deemed an admission that FEHI is the Section 16 beneficial owner of any such securities."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Represents 2,599,340, 517,565 and 1,784,379 shares held directly by 21 April Ltd., FEVIBM and the Separately Managed Accounts, respectively. FEHI disclaims Section 16 beneficial ownership of the shares held directly by the Funds except to the extent, if any, of its pecuniary interest therein, and this report shall not be deemed an admission that FEHI is the Section 16 beneficial owner of any such securities."}],"balance_after":4901284,"source":{"system":"sec-edgar","filing":"0001140361-17-016840","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1001902/000114036117016840/doc1.xml","form_type":"4"}},{"id":4531977,"issuer":{"id":155143,"kind":"organization","name":"ARADIGM CORP","symbol":"ARDM"},"owners":[{"id":50349,"kind":"organization","name":"First Eagle Investment Management, LLC","position":1,"cik":"0001325447","reported_name":"First Eagle Investment Management, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":154711,"kind":"organization","name":"21 APRIL FUND, LTD.","position":2,"cik":"0001459708","reported_name":"21 APRIL FUND, LTD.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":156513,"kind":"organization","name":"21 APRIL FUND, L.P.","position":3,"cik":"0001459688","reported_name":"21 APRIL FUND, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":156514,"kind":"organization","name":"First Eagle Value in Biotechnology Master Fund, Ltd.","position":4,"cik":"0001457518","reported_name":"First Eagle Value in Biotechnology Master Fund, Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrants to purchase Common Stock (right to buy)","published_at":"2016-12-06T17:13:53.000Z","date":"2016-12-02","kind":"purchase","acquired":true,"shares":259117,"price":5.21,"value":1349999.57,"ownership":{"direct":false,"nature":"See Footnotes"},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"See Exhibit 99.1."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"See Exhibit 99.1."},{"field":"shares","element":"transactionShares","label":"F3","text":"See Exhibit 99.1."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"See Exhibit 99.1."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"See Exhibit 99.1."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F3","text":"See Exhibit 99.1."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"See Exhibit 99.1."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"See Exhibit 99.1."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"See Exhibit 99.1."}],"balance_after":259117,"derivative":{"exercise_price":5.21,"exercise_date":"2017-01-10","expiration_date":"2021-07-14","underlying":"Common Stock","underlying_shares":259117},"source":{"system":"sec-edgar","filing":"0001140361-16-088916","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1013238/000114036116088916/doc1.xml","form_type":"4"}},{"id":4566907,"issuer":{"id":75335,"kind":"organization","name":"DURECT CORP","symbol":"DRRX"},"owners":[{"id":50349,"kind":"organization","name":"First Eagle Investment Management, LLC","position":1,"cik":"0001325447","reported_name":"First Eagle Investment Management, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":156513,"kind":"organization","name":"21 APRIL FUND, L.P.","position":2,"cik":"0001459688","reported_name":"21 APRIL FUND, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":154711,"kind":"organization","name":"21 APRIL FUND, LTD.","position":3,"cik":"0001459708","reported_name":"21 APRIL FUND, LTD.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":156514,"kind":"organization","name":"First Eagle Value in Biotechnology Master Fund, Ltd.","position":4,"cik":"0001457518","reported_name":"First Eagle Value in Biotechnology Master Fund, Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":93499,"kind":"organization","name":"First Eagle Holdings, Inc.","position":5,"cik":"0001637141","reported_name":"First Eagle Holdings, Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2016-11-04T15:43:39.000Z","date":"2016-11-03","kind":"purchase","acquired":true,"shares":20000,"price":1.14,"value":22800.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"These shares are indirectly beneficially owned by certain separately managed accounts, including accounts for which FEIM serves as registered investment adviser (the \"Separately Managed Accounts\")."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"The shares of Common Stock reported herein are indirectly beneficially owned by FEHI and FEIM, a Delaware limited liability company and an investment adviser registered under the Investment Advisers Act of 1940.  FEIM is (i) a general partner of April LP, (ii) the registered investment adviser to FEVIBM as well as to April LP and April Ltd. (collectively, the \"Funds\"), (iii) a subsidiary of FEHI and (iv) FEIM is investment adviser to certain of the Separately Managed Accounts. FEHI disclaims Section 16 beneficial ownership of the shares held directly by the Funds except to the extent, if any, of its pecuniary interest therein, and this report shall not be deemed an admission that FEHI is the Section 16 beneficial owner of any such securities."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"Represents 3,426,893, 13,367,709, 5,586,944 and 95,000 shares held directly by 21 April LP, 21 April Ltd., FEVIBM and the Separately Managed Accounts, respectively. FEHI disclaims Section 16 beneficial ownership of the shares held directly by the Funds except to the extent, if any, of its pecuniary interest therein, and this report shall not be deemed an admission that FEHI is the Section 16 beneficial owner of any such securities."}],"balance_after":22476546,"source":{"system":"sec-edgar","filing":"0001140361-16-084885","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1082038/000114036116084885/doc1.xml","form_type":"4"}},{"id":4566906,"issuer":{"id":75335,"kind":"organization","name":"DURECT CORP","symbol":"DRRX"},"owners":[{"id":50349,"kind":"organization","name":"First Eagle Investment Management, LLC","position":1,"cik":"0001325447","reported_name":"First Eagle Investment Management, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":156513,"kind":"organization","name":"21 APRIL FUND, L.P.","position":2,"cik":"0001459688","reported_name":"21 APRIL FUND, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":154711,"kind":"organization","name":"21 APRIL FUND, LTD.","position":3,"cik":"0001459708","reported_name":"21 APRIL FUND, LTD.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":156514,"kind":"organization","name":"First Eagle Value in Biotechnology Master Fund, Ltd.","position":4,"cik":"0001457518","reported_name":"First Eagle Value in Biotechnology Master Fund, Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":93499,"kind":"organization","name":"First Eagle Holdings, Inc.","position":5,"cik":"0001637141","reported_name":"First Eagle Holdings, Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2016-11-04T15:43:39.000Z","date":"2016-11-03","kind":"purchase","acquired":true,"shares":25000,"price":1.1399,"value":28497.5,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"These shares are indirectly beneficially owned by certain separately managed accounts, including accounts for which FEIM serves as registered investment adviser (the \"Separately Managed Accounts\")."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"The shares of Common Stock reported herein are indirectly beneficially owned by FEHI and FEIM, a Delaware limited liability company and an investment adviser registered under the Investment Advisers Act of 1940.  FEIM is (i) a general partner of April LP, (ii) the registered investment adviser to FEVIBM as well as to April LP and April Ltd. (collectively, the \"Funds\"), (iii) a subsidiary of FEHI and (iv) FEIM is investment adviser to certain of the Separately Managed Accounts. FEHI disclaims Section 16 beneficial ownership of the shares held directly by the Funds except to the extent, if any, of its pecuniary interest therein, and this report shall not be deemed an admission that FEHI is the Section 16 beneficial owner of any such securities."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"Represents 3,426,893, 13,367,709, 5,586,944 and 75,000 shares held directly by 21 April LP, 21 April Ltd., FEVIBM and the Separately Managed Accounts, respectively. FEHI disclaims Section 16 beneficial ownership of the shares held directly by the Funds except to the extent, if any, of its pecuniary interest therein, and this report shall not be deemed an admission that FEHI is the Section 16 beneficial owner of any such securities."}],"balance_after":22456546,"source":{"system":"sec-edgar","filing":"0001140361-16-084885","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1082038/000114036116084885/doc1.xml","form_type":"4"}},{"id":4566905,"issuer":{"id":75335,"kind":"organization","name":"DURECT CORP","symbol":"DRRX"},"owners":[{"id":50349,"kind":"organization","name":"First Eagle Investment Management, LLC","position":1,"cik":"0001325447","reported_name":"First Eagle Investment Management, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":156513,"kind":"organization","name":"21 APRIL FUND, L.P.","position":2,"cik":"0001459688","reported_name":"21 APRIL FUND, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":154711,"kind":"organization","name":"21 APRIL FUND, LTD.","position":3,"cik":"0001459708","reported_name":"21 APRIL FUND, LTD.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":156514,"kind":"organization","name":"First Eagle Value in Biotechnology Master Fund, Ltd.","position":4,"cik":"0001457518","reported_name":"First Eagle Value in Biotechnology Master Fund, Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":93499,"kind":"organization","name":"First Eagle Holdings, Inc.","position":5,"cik":"0001637141","reported_name":"First Eagle Holdings, Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2016-11-04T15:43:39.000Z","date":"2016-11-03","kind":"purchase","acquired":true,"shares":50000,"price":1.18,"value":59000.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"This Form 4 is filed by 21 April Fund, LP (\"April LP\"), 21 April Ltd. (\"April Ltd.\"), First Eagle Investment Management, LLC (\"FEIM\"), First Eagle Value in Biotechnology Master Fund, Ltd. (\"FEVIBM\") and First Eagle Holdings, Inc. (\"FEHI\" and, collectively with April LP, April Ltd., FEIM and FEVIBM, the \"Entities\"). The Entities disclaim status as a \"group\" for purposes of this Form 4."},{"field":"shares","element":"transactionShares","label":"F2","text":"These shares are indirectly beneficially owned by certain separately managed accounts, including accounts for which FEIM serves as registered investment adviser (the \"Separately Managed Accounts\")."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"The shares of Common Stock reported herein are indirectly beneficially owned by FEHI and FEIM, a Delaware limited liability company and an investment adviser registered under the Investment Advisers Act of 1940.  FEIM is (i) a general partner of April LP, (ii) the registered investment adviser to FEVIBM as well as to April LP and April Ltd. (collectively, the \"Funds\"), (iii) a subsidiary of FEHI and (iv) FEIM is investment adviser to certain of the Separately Managed Accounts. FEHI disclaims Section 16 beneficial ownership of the shares held directly by the Funds except to the extent, if any, of its pecuniary interest therein, and this report shall not be deemed an admission that FEHI is the Section 16 beneficial owner of any such securities."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Represents 3,426,893, 13,367,709, 5,586,944 and 50,000 shares held directly by 21 April LP, 21 April Ltd., FEVIBM and the Separately Managed Accounts, respectively. FEHI disclaims Section 16 beneficial ownership of the shares held directly by the Funds except to the extent, if any, of its pecuniary interest therein, and this report shall not be deemed an admission that FEHI is the Section 16 beneficial owner of any such securities."}],"balance_after":22431546,"source":{"system":"sec-edgar","filing":"0001140361-16-084885","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1082038/000114036116084885/doc1.xml","form_type":"4"}},{"id":4593588,"issuer":{"id":75335,"kind":"organization","name":"DURECT CORP","symbol":"DRRX"},"owners":[{"id":154711,"kind":"organization","name":"21 APRIL FUND, LTD.","position":1,"cik":"0001459708","reported_name":"21 APRIL FUND, LTD.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":156513,"kind":"organization","name":"21 APRIL FUND, L.P.","position":2,"cik":"0001459688","reported_name":"21 APRIL FUND, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":156514,"kind":"organization","name":"First Eagle Value in Biotechnology Master Fund, Ltd.","position":3,"cik":"0001457518","reported_name":"First Eagle Value in Biotechnology Master Fund, Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":93499,"kind":"organization","name":"First Eagle Holdings, Inc.","position":4,"cik":"0001637141","reported_name":"First Eagle Holdings, Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2016-09-28T12:47:51.000Z","date":"2016-09-26","kind":"purchase","acquired":true,"shares":200000,"price":1.15,"value":230000.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F5","text":"Represents 40,809 and 159,191 shares purchased by 21 April LP and 21 April Ltd., respectively. FEHI disclaims Section 16 beneficial ownership of the shares held directly by the Funds except to the extent, if any, of its pecuniary interest therein, and this report shall not be deemed an admission that FEHI is the Section 16 beneficial owner of any such securities."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F6","text":"Represents 3,426,893, 13,367,709, and 5,586,944 shares held directly by 21 April LP, 21 April Ltd. and FEVIBM, respectively. FEHI disclaims Section 16 beneficial ownership of the shares held directly by the Funds except to the extent, if any, of its pecuniary interest therein, and this report shall not be deemed an admission that FEHI is the Section 16 beneficial owner of any such securities."}],"balance_after":22381546,"source":{"system":"sec-edgar","filing":"0001140361-16-080886","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1082038/000114036116080886/doc1.xml","form_type":"4"}},{"id":4593587,"issuer":{"id":75335,"kind":"organization","name":"DURECT CORP","symbol":"DRRX"},"owners":[{"id":154711,"kind":"organization","name":"21 APRIL FUND, LTD.","position":1,"cik":"0001459708","reported_name":"21 APRIL FUND, LTD.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":156513,"kind":"organization","name":"21 APRIL FUND, L.P.","position":2,"cik":"0001459688","reported_name":"21 APRIL FUND, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":156514,"kind":"organization","name":"First Eagle Value in Biotechnology Master Fund, Ltd.","position":3,"cik":"0001457518","reported_name":"First Eagle Value in Biotechnology Master Fund, Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":93499,"kind":"organization","name":"First Eagle Holdings, Inc.","position":4,"cik":"0001637141","reported_name":"First Eagle Holdings, Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2016-09-28T12:47:51.000Z","date":"2016-09-26","kind":"purchase","acquired":true,"shares":318776,"price":1.1,"value":350653.6,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents 63,678 and 255,098 shares purchased by 21 April LP and 21 April Ltd., respectively. FEHI disclaims Section 16 beneficial ownership of the shares held directly by the Funds except to the extent, if any, of its pecuniary interest therein, and this report shall not be deemed an admission that FEHI is the Section 16 beneficial owner of any such securities."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F4","text":"Represents 3,386,084, 13,208,518, and 5,586,944 shares held directly by 21 April LP, 21 April Ltd. and FEVIBM, respectively. FEHI disclaims Section 16 beneficial ownership of the shares held directly by the Funds except to the extent, if any, of its pecuniary interest therein, and this report shall not be deemed an admission that FEHI is the Section 16 beneficial owner of any such securities."}],"balance_after":22181546,"source":{"system":"sec-edgar","filing":"0001140361-16-080886","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1082038/000114036116080886/doc1.xml","form_type":"4"}},{"id":4593586,"issuer":{"id":75335,"kind":"organization","name":"DURECT CORP","symbol":"DRRX"},"owners":[{"id":154711,"kind":"organization","name":"21 APRIL FUND, LTD.","position":1,"cik":"0001459708","reported_name":"21 APRIL FUND, LTD.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":156513,"kind":"organization","name":"21 APRIL FUND, L.P.","position":2,"cik":"0001459688","reported_name":"21 APRIL FUND, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":156514,"kind":"organization","name":"First Eagle Value in Biotechnology Master Fund, Ltd.","position":3,"cik":"0001457518","reported_name":"First Eagle Value in Biotechnology Master Fund, Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":93499,"kind":"organization","name":"First Eagle Holdings, Inc.","position":4,"cik":"0001637141","reported_name":"First Eagle Holdings, Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2016-09-28T12:47:51.000Z","date":"2016-09-26","kind":"purchase","acquired":true,"shares":1981224,"price":1.16,"value":2298219.84,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents 259,957 and 1,721,267 shares purchased by 21 April Fund, LP (\"21 April LP\") and 21 April Fund, Ltd. (\"21 April Ltd.\"), respectively. First Eagle Investment Management, LLC (\"FEIM\") is (i) a general partner of 21 April LP, (ii) the registered investment adviser to First Eagle Value in Biotechnology Master Fund, Ltd. \"FEVIBM\" as well as to 21 April LP and 21 April Ltd. (collectively, the \"Funds\") and (iii) a subsidiary of First Eagle Holdings, Inc. (\"FEHI\"). FEHI disclaims Section 16 beneficial ownership of the shares held directly by the Funds except to the extent, if any, of its pecuniary interest therein, and this report shall not be deemed an admission that FEHI is the Section 16 beneficial owner of any such securities."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"Represents 3,322,406, 12,953,420, and 5,586,944 shares held directly by 21 April LP, 21 April Ltd. and FEVIBM, respectively. FEHI disclaims Section 16 beneficial ownership of the shares held directly by the Funds except to the extent, if any, of its pecuniary interest therein, and this report shall not be deemed an admission that FEHI is the Section 16 beneficial owner of any such securities."}],"balance_after":21862770,"source":{"system":"sec-edgar","filing":"0001140361-16-080886","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1082038/000114036116080886/doc1.xml","form_type":"4"}}]}